Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	HSPD1 KIF13B MYH7 ANXA5 KIF16B ABCC9 NLRP1 SRPRA ATP9B MSH3 BCS1L DNAH7 BPTF ATP11B ATP1A4 DNAH6 HSPA1L HSPA4 KIF11	4.58e-06	614	185	19	GO:0140657
GeneOntologyMolecularFunction	ATP hydrolysis activity	HSPD1 KIF13B MYH7 KIF16B ABCC9 NLRP1 SRPRA ATP9B BCS1L DNAH7 ATP11B ATP1A4 DNAH6 HSPA1L	6.59e-05	441	185	14	GO:0016887
GeneOntologyMolecularFunction	acylphosphatase activity	ACYP1 ACYP2	8.54e-05	2	185	2	GO:0003998
GeneOntologyBiologicalProcess	microtubule-based movement	KIF13B IFT140 MAP1A ARMC3 MAP1B ANXA5 SUN1 KIF16B OR4M1 DNAH7 ACTR2 MET OR4M2 NPHP3 DST ATP1A4 DNAH6 RHOT1 KIF11	8.19e-08	493	182	19	GO:0007018
GeneOntologyBiologicalProcess	epithelial cell-cell adhesion	DSP SRF SVEP1 VCL	1.63e-05	18	182	4	GO:0090136
GeneOntologyCellularComponent	photoreceptor cell cilium	IFT140 IMPG1 MAP1A MAP1B ADGRV1 PTPRK RP1 ATP1A4	3.14e-05	139	183	8	GO:0097733
GeneOntologyCellularComponent	photoreceptor outer segment	IFT140 IMPG1 MAP1A MAP1B PTPRK RP1 ATP1A4	5.54e-05	111	183	7	GO:0001750
GeneOntologyCellularComponent	9+0 non-motile cilium	IFT140 IMPG1 MAP1A MAP1B ADGRV1 PTPRK RP1 ATP1A4	6.22e-05	153	183	8	GO:0097731
GeneOntologyCellularComponent	cell-cell junction	USP53 DCHS2 ARHGAP24 DSP ANXA5 LCK PLEKHG4B FAT1 KCNA2 DST HMCN1 PTPRJ PTPRK KCNJ2 VCL TBCD	6.72e-05	591	183	16	GO:0005911
GeneOntologyCellularComponent	microtubule associated complex	KIF13B MAP1A MAP1B KIF16B DNAH7 RP1 DNAH6 KIF11	8.89e-05	161	183	8	GO:0005875
GeneOntologyCellularComponent	CD40 receptor complex	TRAF2 TRAF6 DIABLO	1.03e-04	11	183	3	GO:0035631
GeneOntologyCellularComponent	intercalated disc	DSP ANXA5 DST KCNJ2 VCL	3.25e-04	68	183	5	GO:0014704
GeneOntologyCellularComponent	non-motile cilium	IFT140 IMPG1 MAP1A MAP1B ADGRV1 PTPRK RP1 ATP1A4	3.42e-04	196	183	8	GO:0097730
GeneOntologyCellularComponent	IRE1-TRAF2-ASK1 complex	TRAF2 MAP3K5	4.52e-04	4	183	2	GO:1990604
GeneOntologyCellularComponent	anchoring junction	USP53 DCHS2 ARHGAP24 DSP ANXA5 RTN4 PDPK2P LCK ACTR2 PLEKHG4B FAT1 KCNA2 DST HMCN1 PTPRJ PTPRK KCNJ2 VCL TBCD	9.55e-04	976	183	19	GO:0070161
GeneOntologyCellularComponent	A band	PPP2R5A DST NBR1 MYBPC3	1.11e-03	52	183	4	GO:0031672
GeneOntologyCellularComponent	main axon	KIF13B MAP1A MAP1B KCNA2 ROBO1	1.12e-03	89	183	5	GO:0044304
GeneOntologyCellularComponent	interphotoreceptor matrix	IMPG1 RBP3	1.12e-03	6	183	2	GO:0033165
GeneOntologyCellularComponent	cell body	CYBB MAP1A MAP1B KALRN ANXA5 RTN4 PDPK2P MET BPTF KCNA2 PTPRK KCNJ2 ROBO1 HSPA1L NAXE CKMT1A SORL1 GABRA6	1.37e-03	929	183	18	GO:0044297
GeneOntologyCellularComponent	cell-cell contact zone	DSP ANXA5 DST KCNJ2 VCL	1.42e-03	94	183	5	GO:0044291
GeneOntologyCellularComponent	sarcomere	MYH7 ANXA5 ABCC9 PPP2R5A DST NBR1 VCL MYBPC3	1.62e-03	249	183	8	GO:0030017
GeneOntologyCellularComponent	postsynaptic specialization	SYN3 MAP1A MAP1B KALRN RTN4 PDPK2P LCK FAM81A HNRNPH2 DST GRK2 GABRA6	1.64e-03	503	183	12	GO:0099572
Domain	fn3	EPHA6 KALRN DSCAML1 IGSF22 PTPRJ PTPRK ROBO1 SORL1 MYBPC3	2.57e-05	162	178	9	PF00041
Domain	FN3	EPHA6 KALRN DSCAML1 IGSF22 PTPRJ PTPRK ROBO1 SORL1 MYBPC3	7.24e-05	185	178	9	SM00060
Domain	Histone_H3-K9_MeTrfase	SUV39H2 SUV39H1	9.03e-05	2	178	2	IPR011381
Domain	Acylphosphatase	ACYP1 ACYP2	9.03e-05	2	178	2	PF00708
Domain	Acylphosphatase	ACYP1 ACYP2	9.03e-05	2	178	2	IPR020456
Domain	ACYLPHOSPHATASE_3	ACYP1 ACYP2	9.03e-05	2	178	2	PS51160
Domain	SAM_MT43_SUVAR39_3	SUV39H2 SUV39H1	9.03e-05	2	178	2	PS51579
Domain	ACYLPHOSPHATASE_1	ACYP1 ACYP2	9.03e-05	2	178	2	PS00150
Domain	ACYLPHOSPHATASE_2	ACYP1 ACYP2	9.03e-05	2	178	2	PS00151
Domain	Acylphosphatase_CS	ACYP1 ACYP2	9.03e-05	2	178	2	IPR017968
Domain	FN3	EPHA6 KALRN DSCAML1 IGSF22 PTPRJ PTPRK ROBO1 SORL1 MYBPC3	1.26e-04	199	178	9	PS50853
Domain	FN3_dom	EPHA6 KALRN DSCAML1 IGSF22 PTPRJ PTPRK ROBO1 SORL1 MYBPC3	1.83e-04	209	178	9	IPR003961
Domain	HTH_Tnp_Tc5	TIGD7 DCHS2 POGK	2.27e-04	13	178	3	PF03221
Domain	-	SYN3 MCCC1 PC	2.27e-04	13	178	3	3.40.50.20
Domain	Acylphosphatase-like_dom	ACYP1 ACYP2	2.69e-04	3	178	2	IPR001792
Domain	MAP1	MAP1A MAP1B	2.69e-04	3	178	2	IPR026074
Domain	PreATP-grasp_dom	SYN3 MCCC1 PC	2.87e-04	14	178	3	IPR016185
Domain	-	SYN3 MCCC1 PC	3.56e-04	15	178	3	3.30.1490.20
Domain	COE	EBF3 EBF1	5.35e-04	4	178	2	PS01345
Domain	Transcription_factor_COE	EBF3 EBF1	5.35e-04	4	178	2	IPR003523
Domain	COE_HLH	EBF3 EBF1	5.35e-04	4	178	2	IPR032201
Domain	COE_DBD	EBF3 EBF1	5.35e-04	4	178	2	IPR032200
Domain	Transcription_factor_COE_CS	EBF3 EBF1	5.35e-04	4	178	2	IPR018350
Domain	COE1_HLH	EBF3 EBF1	5.35e-04	4	178	2	PF16423
Domain	COE1_DBD	EBF3 EBF1	5.35e-04	4	178	2	PF16422
Domain	ATP_grasp_subdomain_1	SYN3 MCCC1 PC	6.25e-04	18	178	3	IPR013815
Domain	-	SYN3 MCCC1 PC	6.25e-04	18	178	3	3.30.470.20
Domain	-	MAP1A MAP1B INTS11	8.61e-04	20	178	3	3.60.15.10
Domain	Metallo-B-lactamas	MAP1A MAP1B INTS11	8.61e-04	20	178	3	IPR001279
Domain	Biotin_BS	MCCC1 PC	8.86e-04	5	178	2	IPR001882
Domain	Biotin_COase_C	MCCC1 PC	8.86e-04	5	178	2	IPR005482
Domain	BC	MCCC1 PC	8.86e-04	5	178	2	PS50979
Domain	Biotin_carb_C	MCCC1 PC	8.86e-04	5	178	2	SM00878
Domain	Biotin_carb_C	MCCC1 PC	8.86e-04	5	178	2	PF02785
Domain	Biotin_carboxylation_dom	MCCC1 PC	8.86e-04	5	178	2	IPR011764
Domain	BIOTIN	MCCC1 PC	8.86e-04	5	178	2	PS00188
Domain	-	DSP DST	1.32e-03	6	178	2	3.90.1290.10
Domain	Rudment_hybrid_motif	MCCC1 PC	1.32e-03	6	178	2	IPR011054
Domain	TNF_rcpt--assoc_TRAF	TRAF2 TRAF6	1.32e-03	6	178	2	IPR012227
Domain	PHD	KDM4C G2E3 BPTF KDM7A KAT6B	1.62e-03	89	178	5	SM00249
Domain	Znf_PHD	KDM4C G2E3 BPTF KDM7A KAT6B	1.78e-03	91	178	5	IPR001965
Domain	Pre-SET	SUV39H2 SUV39H1	1.84e-03	7	178	2	PF05033
Domain	Plectin	DSP DST	1.84e-03	7	178	2	PF00681
Domain	CbamoylP_synth_lsu-like_ATP-bd	MCCC1 PC	1.84e-03	7	178	2	IPR005479
Domain	BC-like_N	MCCC1 PC	1.84e-03	7	178	2	IPR005481
Domain	PreSET	SUV39H2 SUV39H1	1.84e-03	7	178	2	SM00468
Domain	Plectin_repeat	DSP DST	1.84e-03	7	178	2	IPR001101
Domain	CPSase_L_D2	MCCC1 PC	1.84e-03	7	178	2	PF02786
Domain	Biotin_carb_N	MCCC1 PC	1.84e-03	7	178	2	PF00289
Domain	Pre-SET_dom	SUV39H2 SUV39H1	1.84e-03	7	178	2	IPR007728
Domain	PRE_SET	SUV39H2 SUV39H1	1.84e-03	7	178	2	PS50867
Domain	PLEC	DSP DST	1.84e-03	7	178	2	SM00250
Domain	IPT	EBF3 EBF1 MET	2.10e-03	27	178	3	SM00429
Domain	ZF_PHD_2	KDM4C G2E3 BPTF KDM7A KAT6B	2.16e-03	95	178	5	PS50016
Domain	ZF_PHD_1	KDM4C G2E3 BPTF KDM7A KAT6B	2.26e-03	96	178	5	PS01359
Domain	Ig_I-set	KALRN DSCAML1 IGSF22 HMCN1 PTPRK ROBO1 MYBPC3	2.34e-03	190	178	7	IPR013098
Domain	I-set	KALRN DSCAML1 IGSF22 HMCN1 PTPRK ROBO1 MYBPC3	2.34e-03	190	178	7	PF07679
Domain	zf-TRAF	TRAF2 TRAF6	2.44e-03	8	178	2	PF02176
Domain	K_chnl_volt-dep_Kv1	KCNA2 KCNA3	2.44e-03	8	178	2	IPR003972
Domain	VWF_A	RO60 SVEP1 HMCN1 VWA5A CPNE7	2.58e-03	99	178	5	IPR002035
Domain	Spectrin_repeat	KALRN DSP DST	2.59e-03	29	178	3	IPR002017
Domain	Znf_FYVE_PHD	KDM4C G2E3 WDFY2 BPTF KDM7A KAT6B	2.88e-03	147	178	6	IPR011011
Domain	Biotin_lipoyl	MCCC1 PC	3.11e-03	9	178	2	PF00364
Domain	ATP_grasp_subdomain_2	SYN3 MCCC1 PC	3.14e-03	31	178	3	IPR013816
Domain	TIG	EBF3 EBF1 MET	3.14e-03	31	178	3	PF01833
Domain	IPT	EBF3 EBF1 MET	3.45e-03	32	178	3	IPR002909
Domain	-	ATP9B ATP11B ATP1A4	3.45e-03	32	178	3	3.40.1110.10
Domain	-	ATP9B ATP11B ATP1A4	3.45e-03	32	178	3	2.70.150.10
Domain	SPEC	KALRN DSP DST	3.45e-03	32	178	3	SM00150
Domain	Spectrin/alpha-actinin	KALRN DSP DST	3.45e-03	32	178	3	IPR018159
Domain	BIOTINYL_LIPOYL	MCCC1 PC	3.87e-03	10	178	2	PS50968
Domain	Biotin_lipoyl	MCCC1 PC	3.87e-03	10	178	2	IPR000089
Domain	ATPase_P-typ_cyto_domN	ATP9B ATP11B ATP1A4	4.45e-03	35	178	3	IPR023299
Domain	-	EPHA6 KALRN EBF3 EBF1 DSCAML1 CD84 MET IGSF22 HMCN1 PTPRJ PTPRK ROBO1 SORL1 MYBPC3	4.57e-03	663	178	14	2.60.40.10
Domain	GFP-like	SVEP1 HMCN1	4.69e-03	11	178	2	IPR023413
Domain	-	SVEP1 HMCN1	4.69e-03	11	178	2	2.40.155.10
Domain	ATPase_P-typ_P_site	ATP9B ATP11B ATP1A4	4.82e-03	36	178	3	IPR018303
Domain	P_typ_ATPase	ATP9B ATP11B ATP1A4	4.82e-03	36	178	3	IPR001757
Domain	ATPASE_E1_E2	ATP9B ATP11B ATP1A4	4.82e-03	36	178	3	PS00154
Domain	ATPase_P-typ_transduc_dom_A	ATP9B ATP11B ATP1A4	5.21e-03	37	178	3	IPR008250
Domain	E1-E2_ATPase	ATP9B ATP11B ATP1A4	5.21e-03	37	178	3	PF00122
Domain	-	SVEP1 HMCN1 VWA5A CPNE7	5.46e-03	74	178	4	3.40.50.410
Domain	MATH	TRAF2 TRAF6	5.60e-03	12	178	2	PS50144
Domain	Znf_TRAF	TRAF2 TRAF6	5.60e-03	12	178	2	IPR001293
Domain	Single_hybrid_motif	MCCC1 PC	5.60e-03	12	178	2	IPR011053
Domain	CENPB	TIGD7 POGK	5.60e-03	12	178	2	SM00674
Domain	-	HSPA1L HSPA4	5.60e-03	12	178	2	2.60.34.10
Domain	HSP70_peptide-bd	HSPA1L HSPA4	5.60e-03	12	178	2	IPR029047
Domain	MATH/TRAF_dom	TRAF2 TRAF6	5.60e-03	12	178	2	IPR002083
Domain	MATH	TRAF2 TRAF6	5.60e-03	12	178	2	SM00061
Domain	DDE_1	TIGD7 POGK	5.60e-03	12	178	2	PF03184
Domain	MATH	TRAF2 TRAF6	5.60e-03	12	178	2	PF00917
Domain	DDE_SF_endonuclease_dom	TIGD7 POGK	5.60e-03	12	178	2	IPR004875
Domain	HTH_CENPB	TIGD7 POGK	6.58e-03	13	178	2	PS51253
Domain	ZF_TRAF	TRAF2 TRAF6	6.58e-03	13	178	2	PS50145
Domain	-	HSPA1L HSPA4	6.58e-03	13	178	2	1.20.1270.10
Domain	Heat_shock_70_CS	HSPA1L HSPA4	6.58e-03	13	178	2	IPR018181
Domain	HSP70_C	HSPA1L HSPA4	6.58e-03	13	178	2	IPR029048
Domain	HTH_CenpB_DNA-bd_dom	TIGD7 POGK	6.58e-03	13	178	2	IPR006600
Domain	SET	SUV39H2 PRDM1 SUV39H1	6.96e-03	41	178	3	PF00856
Pathway	WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM	CYBB MAP1B KALRN MAP3K5 TARDBP GRK2 HSPA4 RHOT1	2.47e-05	113	148	8	M48336
Pathway	REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE	PIK3R3 PDPK2P LCK PLCG2 COL1A2	3.00e-05	35	148	5	MM14512
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	USP53 IFT140 EMC1 WASHC4 RTN4 SUN1 KIF16B G2E3 ADGRV1 DST ATP11B KDM7A DAAM1 KAT6B PADI2 NBR1	3.08e-08	529	186	16	14621295
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	HSPD1 AHCYL1 EMC1 SYN3 MAP1A MAP1B KALRN DSP RTN4 SUN1 SRPRA MCCC1 HM13 ACYP1 ACYP2 HNRNPH2 MET TENM4 GRK2 PRRC2C NUFIP2 DAAM1 PC	5.25e-08	1139	186	23	36417873
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	HSPD1 AHCYL1 TRAF2 WASHC4 SRSF6 MAP1B DSP POLA1 PSMA1 ANXA5 MSH3 MCCC1 USP16 HNRNPH2 TARDBP POLR3B DST POLR1E INTS11 PLCG2 RIOK2 HSPA1L HSPA4 VCL KIF11	7.26e-08	1353	186	25	29467282
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	HSPD1 TRAF2 EMC1 ZMPSTE24 DSP PSMA1 RTN4 HM13 ACTR2 HNRNPH2 MET BPTF TARDBP FAT1 DST PRRC2C P3H1 NUFIP2 ROBO1 C3 RIOK2 HSPA4 NBR1 KIF11	1.32e-07	1297	186	24	33545068
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	KIF13B EMC1 WASHC4 MAP1A MAP1B POGK POLA1 MSH3 COPS2 HNRNPH2 TARDBP POLR3B SUV39H1 INTS11 PC RHOT1 KIF11	2.81e-07	704	186	17	29955894
Pubmed	SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling.	HSPD1 TRAF2 SRSF6 MAP1B DSP PSMA1 HNRNPH2 KRT80 TARDBP PRRC2C CCDC87 ATP1A4 HSPA4 KIF11 COL1A2	3.81e-07	558	186	15	27591049
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	USP53 KBTBD3 PRUNE2 EPHA6 MAP1B PSMA1 PIK3R3 SRF G2E3 ATP9B ADGRV1 H6PD HM13 SELENON CUL5 PLEKHG4B BPTF ATP11B PTPRJ PLA2G6 DAAM1 KAT6B NBR1 TBCD CPNE7	4.35e-07	1489	186	25	28611215
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	HSPD1 MYH7 MAP1B DSP PSMA1 ANXA5 AHSA1 KRT80 TARDBP PRRC2C AGK C3 DAAM1 HSPA4 VCL CKMT1A	4.67e-07	647	186	16	26618866
Pubmed	Thioredoxin and TRAF family proteins regulate reactive oxygen species-dependent activation of ASK1 through reciprocal modulation of the N-terminal homophilic interaction of ASK1.	TRAF2 TRAF6 MAP3K5	6.00e-07	4	186	3	17724081
Pubmed	Co-inheritance of mutations associated with arrhythmogenic cardiomyopathy and hypertrophic cardiomyopathy.	MYH7 DSP MYBPC3	6.00e-07	4	186	3	28699631
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	HSPD1 ZMPSTE24 ARMC3 KALRN DSP NT5E PSMA1 ANXA5 ADGRV1 AHSA1 ACTR2 TGFBR3 FAT1 BPI PTPRJ P3H1 PADI2 ENPEP VCL SORL1	6.16e-07	1016	186	20	19056867
Pubmed	Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II.	HSPD1 SRSF6 MCCC1 COPS2 PYHIN1 CUL5 TARDBP PC HSPA1L HSPA4	8.72e-07	244	186	10	30349055
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	HSPD1 EMC1 PSMA1 SUN1 H6PD AHSA1 COPS2 HNRNPH2 MET TARDBP PTPRJ P3H1 AGK KIF11 SORL1	1.23e-06	613	186	15	22268729
Pubmed	Mediation of TNF receptor-associated factor effector functions by apoptosis signal-regulating kinase-1 (ASK1).	TRAF2 TRAF6 MAP3K5	1.49e-06	5	186	3	10523862
Pubmed	SIRT5 is a proviral factor that interacts with SARS-CoV-2 Nsp14 protein.	HSPD1 DSP MCCC1 NUFIP2 C3 PC	1.50e-06	66	186	6	36095012
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	HSPD1 AHCYL1 ZMPSTE24 MAP1B DSP RTN4 SRPRA HM13 KCNA3 DST PRRC2C NUFIP2 AGK ROBO1 HSPA4 VCL	1.51e-06	708	186	16	39231216
Pubmed	Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.	HSPD1 MYH7 ATP9B ADGRV1 HMCN1 PC HSPA1L HSPA4	1.75e-06	152	186	8	34299191
Pubmed	Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein.	HSPD1 SRSF6 MAP1B DIABLO RO60 AHSA1 ACTR2 HNRNPH2 TARDBP PRRC2C NUFIP2 AGK CRYZL1 HSPA1L HSPA4 RHOT1	2.05e-06	725	186	16	27025967
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	HSPD1 TRAF2 EMC1 SRSF6 DIABLO DSP POLA1 PSMA1 ANXA5 RTN4 RO60 MSH3 AHSA1 ACTR2 TARDBP INTS11 AGK PC HSPA4 NBR1 VCL KIF11 CKMT1A	2.54e-06	1425	186	23	30948266
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	HSPD1 AHCYL1 SYN3 MAP1A MAP1B KALRN DSP RTN4 RBP3 ACTR2 CUL5 TENM4 DST GRK2 PRRC2C NUFIP2 MIOS PC DNAH6 HSPA4 VCL RHOT1 CKMT1A	2.73e-06	1431	186	23	37142655
Pubmed	A novel custom resequencing array for dilated cardiomyopathy.	MYH7 ABCC9 VCL MYBPC3	2.88e-06	19	186	4	20474083
Pubmed	TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-kappaB.	TRAF2 TRAF6 DIABLO	2.97e-06	6	186	3	19234489
Pubmed	Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development.	MAP1A MAP1B AHSA1 PRRC2C USP47 KIF11	3.46e-06	76	186	6	27542412
Pubmed	Ankyrin repeat and suppressors of cytokine signaling box protein asb-9 targets creatine kinase B for degradation.	HSPD1 CUL5 HSPA4	5.19e-06	7	186	3	17148442
Pubmed	Proteomic analysis of the mitochondrial glucocorticoid receptor interacting proteins reveals pyruvate dehydrogenase and mitochondrial 60 kDa heat shock protein as potent binding partners.	HSPD1 ZMPSTE24 DSP RTN4 C3 HSPA4	5.79e-06	83	186	6	35124280
Pubmed	Network organization of the huntingtin proteomic interactome in mammalian brain.	HSPD1 SRSF4 MAP1A SYT12 MAP1B ABCC9 MCCC1 AHSA1 TARDBP DST GRK2 ATP1A4 PC CKMT1A	7.17e-06	621	186	14	22794259
Pubmed	ASK1 is essential for JNK/SAPK activation by TRAF2.	TRAF2 TRAF6 MAP3K5	8.26e-06	8	186	3	9774977
Pubmed	FAM46C and FNDC3A Are Multiple Myeloma Tumor Suppressors That Act in Concert to Impair Clearing of Protein Aggregates and Autophagy.	HSPD1 DSP PSMA1 ANXA5 AHSA1 HNRNPH2 TARDBP P3H1 NAXE	8.32e-06	248	186	9	32963011
Pubmed	ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure.	HSPD1 SRSF4 DSP SUN1 HNRNPH2 TARDBP DST PRRC2C NUFIP2 HSPA4	8.45e-06	315	186	10	26777405
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	USP53 KIF13B AHCYL1 MAP1B DIABLO POLA1 COPS2 USP16 CUL5 POLR3B POLR1E P3H1 NUFIP2 MIOS ZNF770 USP47 KIF11 CPNE7	8.46e-06	1005	186	18	19615732
Pubmed	The E3 ubiquitin ligase FBXL6 controls the quality of newly synthesized mitochondrial ribosomal proteins.	HSPD1 MAP1B PSMA1 AHSA1 COPS2 USP16 HNRNPH2 DST VWA5A AGK PC RIOK2 HSPA4	8.79e-06	547	186	13	37267103
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	MAP1A MAP1B POLA1 RTN4 SRPRA MCCC1 USP16 ACTR2 POLR3C GRK2 PRRC2C NUFIP2 SECISBP2 TAGLN VCL	9.17e-06	724	186	15	36232890
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	HSPD1 AHCYL1 WASHC4 SRSF4 SRSF6 MAP1A MAP1B PSMA1 AHSA1 COPS2 ACTR2 HNRNPH2 CUL5 TARDBP BTBD7 PRRC2C PC RIOK2 HSPA1L HSPA4 CKMT1A	1.06e-05	1335	186	21	29229926
Pubmed	Chromosomal mapping in the mouse of eight K(+)-channel genes representing the four Shaker-like subfamilies Shaker, Shab, Shaw, and Shal.	MET KCNA2 KCNA3 COL1A2	1.08e-05	26	186	4	7905852
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	HSPD1 RTN4 SRPRA MSH3 MCCC1 AHSA1 COPS2 BCS1L PPP2R5A POLR3B AGK TBCD KIF11	1.13e-05	560	186	13	35241646
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	AHCYL1 EMC1 MAP1B POGK RTN4 SRPRA CUL5 DST PRRC2C MICU2 RIOK2 COG4 RHOT1 SORL1	1.20e-05	650	186	14	38777146
Pubmed	LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway.	HSPD1 ANXA5 RTN4 DST HMCN1 HSPA1L VCL	1.21e-05	142	186	7	30809309
Pubmed	ARRB1 ameliorates liver ischaemia/reperfusion injury via antagonizing TRAF6-mediated Lysine 6-linked polyubiquitination of ASK1 in hepatocytes.	TRAF2 TRAF6 MAP3K5	1.23e-05	9	186	3	32445435
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	HSPD1 MYH7 SRSF4 MAP1B DSP PSMA1 ANXA5 AHSA1 COPS2 ACTR2 TARDBP DST PRRC2C NUFIP2 HSPA1L HSPA4 NAXE VCL KIF11	1.44e-05	1149	186	19	35446349
Pubmed	Loss of Super-Enhancer-Regulated circRNA Nfix Induces Cardiac Regeneration After Myocardial Infarction in Adult Mice.	PC VCL COL1A2 MYBPC3	1.47e-05	28	186	4	30947518
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	EMC1 DSP PIK3R3 SUN1 SRPRA TARDBP WWC2 PPP2R5A PTPRJ PTPRK P3H1 NUFIP2 INTS11 MIOS ROBO1 PC NBR1 COL1A2	1.50e-05	1049	186	18	27880917
Pubmed	PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.	SRSF4 SRSF6 MAP1B DSP RO60 HNRNPH2 TARDBP POLR1E PRRC2C NUFIP2 SECISBP2 HSPA4 KIF11 CKMT1A	1.91e-05	678	186	14	30209976
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	DCHS2 AHCYL1 TRAF2 TRAF6 WASHC4 KALRN DSP KDM4C MSH3 MED13L USP16 DSCAML1 POLR3B DST PTPRK ROBO1 PC PADI2 COG4 USP47	2.02e-05	1285	186	20	35914814
Pubmed	Physiological and pathophysiological characteristics of ataxin-3 isoforms.	HSPD1 TRAF2 DIABLO DSP PSMA1 NUFIP2 PC HSPA1L HSPA4	2.24e-05	281	186	9	30455355
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	HSPD1 EMC1 SRSF4 SRSF6 MAP1A MAP1B KALRN DSP EBF3 ANXA5 HNRNPH2 BPTF TARDBP DST INTS11 MIOS AGK COG4	2.26e-05	1082	186	18	38697112
Pubmed	Interactome Analysis of Human Phospholipase D and Phosphatidic Acid-Associated Protein Network.	EMC1 RTN4 SRPRA RO60 HM13 SELENON ACTR2 HNRNPH2 NAXE	2.30e-05	282	186	9	35007762
Pubmed	Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication.	CYBB SRSF6 PSMA1 NLRP1 NPHP3 GRK2 PTPRJ POLR1E GAREM1	2.37e-05	283	186	9	18854154
Pubmed	Nox2 and Rac1 regulate H2O2-dependent recruitment of TRAF6 to endosomal interleukin-1 receptor complexes.	CYBB TRAF6 HSPA4	2.41e-05	11	186	3	16354686
Pubmed	Role of FIP200 in cardiac and liver development and its regulation of TNFalpha and TSC-mTOR signaling pathways.	TRAF2 MAP3K5 VCL	2.41e-05	11	186	3	17015619
Pubmed	Dilated Cardiomyopathy Overview	MYH7 ABCC9 VCL MYBPC3	2.53e-05	32	186	4	20301486
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	EMC1 ZMPSTE24 SYT12 MAP1B RTN4 SUN1 SLC35A1 SRPRA H6PD HM13 SELENON MET FAT1 PTPRJ PTPRK P3H1 ROBO1 NAXE SORL1	2.64e-05	1201	186	19	35696571
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	HSPD1 TRAF2 MSH3 MCCC1 MET BPTF DST PRRC2C PC HSPA4	2.66e-05	360	186	10	33111431
Pubmed	Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains.	SUV39H2 SUV39H1	2.84e-05	2	186	2	14690610
Pubmed	Partitioning and plasticity of repressive histone methylation states in mammalian chromatin.	SUV39H2 SUV39H1	2.84e-05	2	186	2	14690609
Pubmed	The 60- and 70-kDa heat-shock proteins and their correlation with cardiovascular risk factors in postmenopausal women with metabolic syndrome.	HSPD1 HSPA4	2.84e-05	2	186	2	24327239
Pubmed	Different immunohistochemical levels of Hsp60 and Hsp70 in a subset of brain tumors and putative role of Hsp60 in neuroepithelial tumorigenesis.	HSPD1 HSPA4	2.84e-05	2	186	2	23807299
Pubmed	Regulation of microtubule-associated protein 1B (MAP1B) subunit composition.	MAP1A MAP1B	2.84e-05	2	186	2	11002287
Pubmed	Genetic screening for hypertrophic cardiomyopathy in large, asymptomatic military cohorts.	MYH7 MYBPC3	2.84e-05	2	186	2	32030882
Pubmed	Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathy.	MYH7 MYBPC3	2.84e-05	2	186	2	29053178
Pubmed	[No Effect of the p.Arg230His Variant Of The VCL Protein on the Course of the Hypertrophic Cardiomyopathy In Russian Family Carrying The p.Gln1233Ter Pathogenic Variant In The MYBPC3 Gene].	VCL MYBPC3	2.84e-05	2	186	2	37061858
Pubmed	A low prevalence of MYH7/MYBPC3 mutations among familial hypertrophic cardiomyopathy patients in India.	MYH7 MYBPC3	2.84e-05	2	186	2	21959974
Pubmed	Worse prognosis with gene mutations of beta-myosin heavy chain than myosin-binding protein C in Chinese patients with hypertrophic cardiomyopathy.	MYH7 MYBPC3	2.84e-05	2	186	2	18383048
Pubmed	Serine- and arginine-rich proteins 55 and 75 (SRp55 and SRp75) induce production of HIV-1 vpr mRNA by inhibiting the 5'-splice site of exon 3.	SRSF4 SRSF6	2.84e-05	2	186	2	20685659
Pubmed	Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases.	SUV39H2 SUV39H1	2.84e-05	2	186	2	14702045
Pubmed	Suv39h-catalyzed H3K9me3 is critical for euchromatic genome organization and the maintenance of gene transcription.	SUV39H2 SUV39H1	2.84e-05	2	186	2	38719473
Pubmed	The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: a unique profile of both independent and founder events.	MYH7 MYBPC3	2.84e-05	2	186	2	10521296
Pubmed	The mouse and rat MAP1B genes: genomic organization and alternative transcription.	MAP1A MAP1B	2.84e-05	2	186	2	9615228
Pubmed	Dissecting the N-terminal myosin binding site of human cardiac myosin-binding protein C. Structure and myosin binding of domain C2.	MYH7 MYBPC3	2.84e-05	2	186	2	17192269
Pubmed	Genes frequently associated with sudden death in primary hypertrophic cardiomyopathy.	MYH7 MYBPC3	2.84e-05	2	186	2	31996869
Pubmed	Cloning of human microtubule-associated protein 1B and the identification of a related gene on chromosome 15.	MAP1A MAP1B	2.84e-05	2	186	2	7806212
Pubmed	Lck Inhibits Heat Shock Protein 65-Mediated Reverse Cholesterol Transport in T Cells.	HSPD1 LCK	2.84e-05	2	186	2	27742830
Pubmed	Early changes of the heat-shock protein 60 to 70 ratio as prediction of miscarriage in pregnancy.	HSPD1 HSPA4	2.84e-05	2	186	2	30614112
Pubmed	Expression and chromosomal localization of a lymphocyte K+ channel gene.	KCNA2 KCNA3	2.84e-05	2	186	2	2251283
Pubmed	Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage.	MYH7 MYBPC3	2.84e-05	2	186	2	29121657
Pubmed	Hypertrophic cardiomyopathy: a practical approach to guideline directed management.	MYH7 MYBPC3	2.84e-05	2	186	2	34600606
Pubmed	Cutting Edge: A Cullin-5-TRAF6 Interaction Promotes TRAF6 Polyubiquitination and Lipopolysaccharide Signaling.	TRAF6 CUL5	2.84e-05	2	186	2	27233966
Pubmed	Differential voltage-dependent K+ channel responses during proliferation and activation in macrophages.	KCNA3 KCNJ2	2.84e-05	2	186	2	12923194
Pubmed	Circulating anti-heat-shock-protein antibodies in normal pregnancy and preeclampsia.	HSPD1 HSPA4	2.84e-05	2	186	2	19205928
Pubmed	The methyltransferase Suv39h1 links the SUMO pathway to HP1α marking at pericentric heterochromatin.	SUV39H2 SUV39H1	2.84e-05	2	186	2	27426629
Pubmed	Inactivation of serum response factor contributes to decrease vascular muscular tone and arterial stiffness in mice.	SRF TAGLN	2.84e-05	2	186	2	23426017
Pubmed	Neuronal abnormalities in microtubule-associated protein 1B mutant mice.	MAP1A MAP1B	2.84e-05	2	186	2	8577753
Pubmed	Biallelic mutation in MYH7 and MYBPC3 leads to severe cardiomyopathy with left ventricular noncompaction phenotype.	MYH7 MYBPC3	2.84e-05	2	186	2	30924982
Pubmed	H3K56me3 is a novel, conserved heterochromatic mark that largely but not completely overlaps with H3K9me3 in both regulation and localization.	SUV39H2 SUV39H1	2.84e-05	2	186	2	23451023
Pubmed	Suv39h-dependent H3K9me3 marks intact retrotransposons and silences LINE elements in mouse embryonic stem cells.	SUV39H2 SUV39H1	2.84e-05	2	186	2	24981170
Pubmed	Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy.	MYH7 MYBPC3	2.84e-05	2	186	2	28193612
Pubmed	Cloning and expression of the cDNA coding for the erythrocyte isoenzyme of human acylphosphatase.	ACYP1 ACYP2	2.84e-05	2	186	2	7796909
Pubmed	Diclofenac inhibits Kv1.3 and Kir2.1 expressions in human macrophages and affects the membrane potential and foam cell formation.	KCNA3 KCNJ2	2.84e-05	2	186	2	22931594
Pubmed	Heat shock proteins 60 and 70 are associated with long-term outcome of T1-stage high-grade urothelial tumors of the bladder treated with intravesical Bacillus Calmette-Guérin immunotherapy.	HSPD1 HSPA4	2.84e-05	2	186	2	30337218
Pubmed	Mutation-specific pathology and treatment of hypertrophic cardiomyopathy in patients, mouse models and human engineered heart tissue.	MYH7 MYBPC3	2.84e-05	2	186	2	32217077
Pubmed	Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy.	MYH7 MYBPC3	2.84e-05	2	186	2	37409452
Pubmed	Cardiovascular magnetic resonance detects microvascular dysfunction in a mouse model of hypertrophic cardiomyopathy.	MYH7 MYBPC3	2.84e-05	2	186	2	34053450
Pubmed	A Murine Hypertrophic Cardiomyopathy Model: The DBA/2J Strain.	MYH7 MYBPC3	2.84e-05	2	186	2	26241864
Pubmed	Reduced Histone H3 Lysine 9 Methylation Contributes to the Pathogenesis of Latent Autoimmune Diabetes in Adults via Regulation of SUV39H2 and KDM4C.	KDM4C SUV39H2	2.84e-05	2	186	2	28396876
Pubmed	Myocardial Deformation Analysis in MYBPC3 and MYH7 Related Sarcomeric Hypertrophic Cardiomyopathy-The Graz Hypertrophic Cardiomyopathy Registry.	MYH7 MYBPC3	2.84e-05	2	186	2	34680864
Pubmed	Heat shock proteins in children and young adults on chronic hemodialysis.	HSPD1 HSPA4	2.84e-05	2	186	2	19475432
Pubmed	Microtubule stability, Golgi organization, and transport flux require dystonin-a2-MAP1B interaction.	MAP1B DST	2.84e-05	2	186	2	22412020
Pubmed	Genetic Testing Yield and Clinical Characteristics of Hypertrophic Cardiomyopathy in Understudied Ethnic Groups: Insights From a New Zealand National Registry.	MYH7 MYBPC3	2.84e-05	2	186	2	38456273
Pubmed	A new acylphosphatase isoenzyme from human erythrocytes: purification, characterization, and primary structure.	ACYP1 ACYP2	2.84e-05	2	186	2	3026468
Pubmed	Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability.	SUV39H2 SUV39H1	2.84e-05	2	186	2	11701123
Pubmed	Extreme disruption of heterochromatin is required for accelerated hematopoietic aging.	SUV39H2 SUV39H1	2.84e-05	2	186	2	32305044
Interaction	ASB9 interactions	HSPD1 ANXA5 LCK CUL5 PLCG2 HSPA4 CKMT1A	1.49e-07	46	178	7	int:ASB9
Interaction	CFTR interactions	HSPD1 AHCYL1 MYH7 SYT12 MAP1B DSP PSMA1 ANXA5 ZFP57 CFHR5 MCCC1 OR5M8 AHSA1 ACTR2 HNRNPH2 KRT80 PRDM1 TARDBP PRRC2C AGK ZNF770 C3 DAAM1 HSPA1L HSPA4 VCL RHOT1 GAREM1 CKMT1A SORL1	1.57e-05	1480	178	30	int:CFTR
Interaction	MAPT interactions	HSPD1 TRAF6 EMC1 SRSF4 SRSF6 MAP1A MAP1B ANXA5 RTN4 SRPRA LCK AHSA1 BCS1L ACTR2 CUL5 TARDBP PPP2R5A NUFIP2 PLCG2 TAGLN HSPA1L HSPA4 RHOT1 TBCD CKMT1A	1.79e-05	1119	178	25	int:MAPT
Interaction	SNCA interactions	TRAF6 SRSF4 SYN3 MAP1B DSP PSMA1 RTN4 SRPRA HNRNPH2 TARDBP DST GRK2 P3H1 TAGLN HSPA1L HSPA4 NBR1 USP47 TBCD	2.00e-05	716	178	19	int:SNCA
Interaction	DNAJC5 interactions	AHCYL1 TRAF6 SYT12 DIABLO PIK3R3 KIF16B MET NUFIP2 ROBO1 DAAM1 HSPA1L HSPA4 VCL	3.29e-05	378	178	13	int:DNAJC5
Interaction	GAPDH interactions	HSPD1 TIGD7 ARHGAP24 EMC1 MAP1B DSP RO60 ACTR2 MAP3K5 MET TARDBP SAMD9L KCNA3 PRRC2C NUFIP2 HSPA1L HSPA4 NBR1	3.87e-05	686	178	18	int:GAPDH
Interaction	COPS5 interactions	HSPD1 DCHS2 AHCYL1 TRAF2 EMC1 SRSF6 DSP PSMA1 SRPRA RO60 HM13 COPS2 HNRNPH2 KRT80 CUL5 FBXO9 NUFIP2 ATP1A4 MICU2 HSPA1L HSPA4 CPNE7 TRMT61A SORL1	4.02e-05	1102	178	24	int:COPS5
GeneFamily	Fibronectin type III domain containing	EPHA6 KALRN DSCAML1 IGSF22 PTPRJ PTPRK PTPRQ ROBO1 SORL1 MYBPC3	3.89e-07	160	137	10	555
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRJ PTPRK PTPRQ	5.12e-04	21	137	3	813
GeneFamily	TNF receptor associated factors	TRAF2 TRAF6	1.17e-03	7	137	2	1056
GeneFamily	RNA polymerase subunits	POLR3C POLR3B POLR1E	1.35e-03	29	137	3	726
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	KALRN DSCAML1 IGSF22 HMCN1 ROBO1 MYBPC3	1.43e-03	161	137	6	593
GeneFamily	EF-hand domain containing\|Plakins	DSP DST	1.55e-03	8	137	2	939
Coexpression	GSE32255_UNSTIM_VS_4H_LPS_STIM_DC_UP	NT5E COPS2 PRDM1 CD84 KCNA2 KCNA3 DST VWA5A PLA2G6 CRYZL1	7.57e-07	186	182	10	M8914
Coexpression	ONDER_CDH1_SIGNALING_VIA_CTNNB1	PRUNE2 MAP1B MIOS C3 TAGLN SORL1 COL1A2	2.00e-06	84	182	7	M15484
Coexpression	SCHLOSSER_SERUM_RESPONSE_DN	WASHC4 KALRN PSMA1 RTN4 PIK3R3 SUN1 SLC35A1 SRPRA ACYP2 ACTR2 HNRNPH2 MAP3K5 ATP11B HIBCH PTPRK PRRC2C MICU2 HSPA4	2.26e-06	705	182	18	M1410
Coexpression	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN	HSPD1 AHCYL1 DSP RTN4 MSH3 COPS2 FAT1 DST FBXO9 HIBCH FGF1 MICU2 PC ENPEP HSPA4	8.04e-06	553	182	15	M1475
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	WASHC4 MAP1B KDM4C MSH3 MED13L TGFBR3 BPTF FAT1 PPP2R5A DST ATP11B PTPRK PRRC2C DAAM1 MICU2 KAT6B VCL KIF11 COL1A2	8.76e-06	856	182	19	M4500
Coexpression	GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_UP	AHCYL1 PSMA1 RO60 MSH3 MCCC1 COPS2 C3 VCL KIF11	1.07e-05	198	182	9	M5774
Coexpression	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	AHCYL1 WASHC4 ZMPSTE24 ANXA5 MSH3 COPS2 ACTR2 HNRNPH2 TARDBP FAT1 DST FBXO9 HIBCH MICU2 COL1A2	1.10e-05	568	182	15	M4023
Coexpression	GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_DN	HSPD1 NT5E SLFN12 SUV39H2 HNRNPH2 TARDBP SAMD9L SUV39H1 MIOS	1.16e-05	200	182	9	M6039
Coexpression	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	CCDC186 PIK3R3 SLC35A1 ADGRV1 MCCC1 KRT80 MAP3K5 WWC2 NPHP3 PTPRK MIOS KDM7A TAGLN GAREM1	1.25e-05	504	182	14	M2157
Coexpression	GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG2_AND_FOXP3_TRASDUCED_DN	KIF16B RO60 H6PD BCS1L WDFY2 KRT80 PADI2 TBCD	1.54e-05	158	182	8	M8993
Coexpression	CUI_TCF21_TARGETS_2_DN	CYBB ARHGAP24 WASHC4 DSP KDM4C NT5E RO60 EBF1 H6PD ZNF518A PRDM1 TGFBR3 WWC2 DST PTPRJ CLEC4A KDM7A VCL	3.02e-05	854	182	18	M1533
Coexpression	LAKE_ADULT_KIDNEY_C28_INTERSTITIUM	USP53 KALRN EBF1 MED13L MAP3K5 DST	3.06e-05	86	182	6	M39247
Coexpression	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	HSPD1 WASHC4 SRSF6 G2E3 USP16 ACTR2 KRT80 POLR3C CUL5 ATP11B RBAK MIOS RIOK2 HSPA4 USP47 KIF11	4.65e-05	721	182	16	M10237
Coexpression	CUI_TCF21_TARGETS_2_DN	CYBB ARHGAP24 DSP KDM4C NT5E RO60 EBF1 H6PD ZNF518A PYHIN1 PRDM1 TGFBR3 WWC2 DST PTPRJ CLEC4A KDM7A VCL	5.01e-05	888	182	18	MM1018
Coexpression	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN	HSPD1 SRSF6 SYT12 PIK3R3 ACYP2 BPTF NPHP3 FBXO9 NUFIP2 ROBO1 C3 NBR1 GAREM1 SORL1 WDR72	5.04e-05	648	182	15	M14371
Coexpression	GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN	KDM4C CCDC186 SLC35A1 MED13L CUL5 BTBD7 KDM7A SORL1	6.65e-05	194	182	8	M7306
Coexpression	HALLMARK_UV_RESPONSE_DN	MAP1B KALRN PIK3R3 TGFBR3 MET MIOS COL1A2	6.84e-05	144	182	7	M5942
Coexpression	GSE27291_0H_VS_6H_STIM_GAMMADELTA_TCELL_DN	AHCYL1 ZMPSTE24 RO60 SELENON SUV39H1 SECISBP2 ATP1A4 WDR72	7.14e-05	196	182	8	M8453
Coexpression	BROWNE_HCMV_INFECTION_30MIN_DN	KALRN DSP NLRP1 RO60 DST VWA5A MIOS	7.15e-05	145	182	7	M0
Coexpression	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	MAP1B POGK POLA1 ACP5 SRPRA RO60 USP16 ACTR2 POLR3C NUFIP2 VCL KIF11 COL1A2	7.38e-05	519	182	13	M3395
Coexpression	GSE45739_NRAS_KO_VS_WT_UNSTIM_CD4_TCELL_DN	PRUNE2 NT5E PIK3R3 EBF1 PPP2R5A SAMD9L NPHP3 CRYZL1	7.40e-05	197	182	8	M9879
Coexpression	GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_DN	KDM4C NT5E PPP2R5A SECISBP2 DAAM1 HSPA4 VCL RHOT1	7.67e-05	198	182	8	M3248
Coexpression	GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_UP	KIF13B AHCYL1 DNAH7 POLR3C PPP2R5A MIOS PLCG2 PC	7.67e-05	198	182	8	M5170
Coexpression	GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN	ACP5 H6PD USP16 WDFY2 HNRNPH2 TGFBR3 GRK2 PLA2G6	7.94e-05	199	182	8	M6660
Coexpression	GSE40274_HELIOS_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	ACP5 ACTR2 CD84 TGFBR3 AGK ROBO1 ZNF770 COL1A2	7.94e-05	199	182	8	M9168
Coexpression	GSE43955_1H_VS_20H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN	MYH7 EPHA6 ACP5 PRDM1 MET TAGLN VCL COL1A2	8.22e-05	200	182	8	M9677
Coexpression	GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_DN	KIF13B SYN3 KDM4C NT5E PTPRJ VWA5A KDM7A DAAM1	8.22e-05	200	182	8	M5043
Coexpression	GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP	WASHC4 POGK CCDC186 PIK3R3 SLC35A1 PRDM1 NUFIP2 DAAM1	8.22e-05	200	182	8	M5069
Coexpression	GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_UP	WASHC4 G2E3 MSH3 MED13L GRK2 SUV39H1 USP47 KIF11	8.22e-05	200	182	8	M8959
Coexpression	GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_UP	DIABLO SRF H6PD AHSA1 HIBCH SECISBP2 RHOT1 KIF11	8.22e-05	200	182	8	M7688
Coexpression	GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_UP	SYN3 KDM4C ACP5 DNAH7 CUL5 PPP2R5A KCNA3 PC	8.22e-05	200	182	8	M5241
Coexpression	LAKE_ADULT_KIDNEY_C21_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_B	KIF13B MAP3K5 PTPRJ PLCG2 GAREM1 WDR72	8.45e-05	103	182	6	M39240
Coexpression	SHEN_SMARCA2_TARGETS_DN	HYAL4 MAP1A KALRN CYP3A4 SULT1B1 GRK2 FGF1 C3 CPNE7 TRMT61A	9.04e-05	322	182	10	M1676
Coexpression	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN	RTN4 NLRP1 USP16 MAP3K5 PRDM1 CD84 CUL5 TGFBR3 TARDBP USP47	9.28e-05	323	182	10	M12570
Coexpression	LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES	KALRN EBF1 MED13L MAP3K5 DST TAGLN VCL	1.09e-04	155	182	7	M39246
Coexpression	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	MAP1B POGK POLA1 ACP5 SRPRA RO60 USP16 ACTR2 POLR3C NUFIP2 VCL KIF11 COL1A2	1.16e-04	543	182	13	MM997
Coexpression	ENK_UV_RESPONSE_KERATINOCYTE_DN	HSPD1 PIK3R3 SLC35A1 SRF RO60 ACYP1 COPS2 ACTR2 MAP3K5 BPTF FAT1 SORL1	1.45e-04	481	182	12	M3898
Coexpression	JOHNSTONE_PARVB_TARGETS_2_DN	ZMPSTE24 SRSF4 SLC35A1 RO60 CUL5 DST FBXO9 ATP11B NUFIP2 HSPA4	1.55e-04	344	182	10	M2239
Coexpression	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D	USP53 TRAF2 SRSF4 HJURP TTYH2 PDPK2P ACYP2 NPHP3 TENM4 HIBCH CCDC87 ZNF770 PLA2G6 CRYZL1 PC COG4 TBCD	1.62e-04	888	182	17	MM1315
Coexpression	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN	EMC1 ZMPSTE24 SRSF4 CCDC186 PIK3R3 H6PD LCK SELENON ZNF518A CUL5 TARDBP TENM4 P3H1 INTS11 KAT6B KIF11	1.71e-04	807	182	16	M14594
Coexpression	ESC_J1_UP_EARLY.V1_DN	SYT12 ANXA5 ZFP57 ATP9B VWA5A TAGLN RIOK2	2.07e-04	172	182	7	M2763
Coexpression	GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP	CYBB ANXA5 TTYH2 MET SAMD9L PTPRJ C3	2.30e-04	175	182	7	M7625
Coexpression	KANG_AR_TARGETS_DN	ANXA5 FGF1 COL1A2	2.49e-04	18	182	3	MM892
Coexpression	KANG_AR_TARGETS_DN	ANXA5 FGF1 COL1A2	2.49e-04	18	182	3	M2225
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN	PRUNE2 SRSF6 MSH3 SELENON FAM81A MET FAT1 MIOS DAAM1 HSPA4 TBCD	2.60e-04	438	182	11	M227
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HPROGM	ARHGAP24 ARMC3 ANXA5 HJURP SRF ADGRV1 DNAH7 FAT1 KIF11	3.11e-04	307	182	9	M39058
Coexpression	WINTER_HYPOXIA_METAGENE	HSPD1 SRSF6 NT5E ANXA5 MET BPI ENPEP SORL1	3.11e-04	243	182	8	M14072
Coexpression	AIZARANI_LIVER_C39_EPCAM_POS_BILE_DUCT_CELLS_4	DSP ANXA5 RTN4 KRT80 MET DST VCL	3.12e-04	184	182	7	M39135
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	HSPD1 ARHGAP24 WASHC4 SRSF6 PSMA1 SUN1 ATP9B RO60 MSH3 COPS2 MAP3K5 POLR3C CUL5 HIBCH MIOS DAAM1 MICU2 HSPA4 VCL RHOT1	3.16e-04	1215	182	20	M41122
Coexpression	GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_UP	KALRN H6PD SELENON SVEP1 WWC2 DST PADI2	3.22e-04	185	182	7	M8792
Coexpression	ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP	HSPD1 USP53 SUN1 COPS2 USP16 ZNF518A CUL5 TGFBR3 SAMD9L HIBCH RBAK ZNF770 MICU2 USP47	3.34e-04	687	182	14	M41022
Coexpression	GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP	AHCYL1 MAP1B ANXA5 NDST4 SUV39H2 CUL5 CCDC87	3.67e-04	189	182	7	M8668
Coexpression	XIE_ST_HSC_S1PR3_OE_UP	KALRN LCK SAMD9L KCNA3 HMCN1 VWA5A VCL	3.67e-04	189	182	7	M41755
Coexpression	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D	USP53 TRAF2 SRSF4 HJURP TTYH2 ACYP2 NPHP3 TENM4 HIBCH CCDC87 ZNF770 PLA2G6 CRYZL1 PC COG4 TBCD	3.70e-04	865	182	16	M2417
Coexpression	RB_P130_DN.V1_DN	ARHGAP24 ZMPSTE24 DSP KIF16B ATP9B USP47	3.85e-04	136	182	6	M2803
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	WASHC4 MAP1B MED13L BPTF FAT1 DST ATP11B PTPRK PRRC2C KAT6B KIF11	4.38e-04	466	182	11	M13522
Coexpression	PLASARI_NFIC_TARGETS_BASAL_DN	EBF3 VWA5A ENPEP	4.60e-04	22	182	3	M2449
Coexpression	GSE3982_BCELL_VS_TH2_UP	NT5E ACP5 KIF16B BPI KDM7A TAGLN VCL	4.70e-04	197	182	7	M5554
Coexpression	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_UP	PIK3R3 POLR3C	4.73e-04	5	182	2	M5076
Coexpression	GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_DN	HYAL4 MYH7 SUN1 ATP9B GRK2 PLCG2 COL1A2	4.85e-04	198	182	7	M5010
Coexpression	GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_UP	POGK HM13 USP16 SUV39H2 MIOS DAAM1 TRMT61A	4.85e-04	198	182	7	M7837
Coexpression	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN	HSPD1 RTN4 PIK3R3 AHSA1 COL1A2	4.85e-04	93	182	5	M4752
Coexpression	GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDC_DN	DIABLO PSMA1 GRK2 PLA2G6 C1QTNF4 HSPA4 RHOT1	4.99e-04	199	182	7	M3836
Coexpression	GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_UP	NT5E ANXA5 COPS2 USP16 PRDM1 BTBD7 PRRC2C	4.99e-04	199	182	7	M7712
Coexpression	GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN	AHCYL1 PSMA1 MSH3 BPTF FBXO9 CLEC4A VCL	4.99e-04	199	182	7	M5799
Coexpression	GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP	SRSF6 KALRN KDM4C USP16 PTPRJ KDM7A TAGLN	5.14e-04	200	182	7	M9449
Coexpression	GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_DN	PIK3R3 TTYH2 MAP3K5 PYHIN1 TGFBR3 PTPRJ PLCG2	5.14e-04	200	182	7	M4656
Coexpression	GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_UP	HYAL4 ACTR2 WWC2 GRK2 RP1 PLCG2 SORL1	5.14e-04	200	182	7	M5973
Coexpression	GSE11961_UNSTIM_VS_ANTI_IGM_AND_CD40_STIM_6H_FOLLICULAR_BCELL_DN	IFT140 ARMC3 RO60 POLR3C SULT1B1 PPP2R5A KCNA3	5.14e-04	200	182	7	M9335
Coexpression	GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_UP	CYBB ARHGAP24 LCK POLR3C BPTF PTPRK BTBD7	5.14e-04	200	182	7	M3251
Coexpression	GSE27786_CD4_TCELL_VS_NEUTROPHIL_DN	ARHGAP24 ARMC3 KRT80 ZNF518A PPP2R5A CRYZL1 USP47	5.14e-04	200	182	7	M4832
Coexpression	GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_DN	TTYH2 PYHIN1 CD84 TGFBR3 KCNA2 ROBO1 PLA2G6	5.14e-04	200	182	7	M8618
Coexpression	GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_UP	CYBB KALRN ACP5 MED13L PTPRJ C3 VCL	5.14e-04	200	182	7	M8657
Coexpression	GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_UP	HSPD1 ANXA5 AHSA1 MAP3K5 PTPRJ AGK C3	5.14e-04	200	182	7	M9900
Coexpression	GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_UP	CYBB AHCYL1 PSMA1 ACP5 COPS2 PRDM1 C3	5.14e-04	200	182	7	M7135
Coexpression	GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP	CYBB MCCC1 DSCAML1 PLCG2 DAAM1 VCL COL1A2	5.14e-04	200	182	7	M6212
Coexpression	GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_UP	EMC1 ZMPSTE24 SRSF6 NT5E COPS2 USP16 POLR3C	5.14e-04	200	182	7	M8860
Coexpression	GSE17721_PAM3CSK4_VS_CPG_6H_BMDC_DN	KALRN LCK POLR3C SUV39H1 C1QTNF4 USP47 SORL1	5.14e-04	200	182	7	M3864
Coexpression	GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_DN	HJURP MED13L CD84 BTBD7 PADI2 NBR1 COG4	5.14e-04	200	182	7	M6411
Coexpression	GSE3039_CD4_TCELL_VS_ALPHAALPHA_CD8_TCELL_DN	ZMPSTE24 POLA1 PSMA1 SAMD9L NPHP3 CLEC4A CRYZL1	5.14e-04	200	182	7	M6457
Coexpression	GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TREATED_CD4_TCELL_DN	ARHGAP24 CCDC186 KIF16B BCS1L KCNA3 ATP11B C3	5.14e-04	200	182	7	M7863
Coexpression	GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP	SYN3 PIK3R3 MSH3 SVEP1 PLCG2 PC NBR1	5.14e-04	200	182	7	M5261
Coexpression	GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_UP	AHCYL1 EMC1 ANXA5 CLEC4A BTBD7 C3 KIF11	5.14e-04	200	182	7	M5503
Coexpression	PLASARI_NFIC_TARGETS_BASAL_DN	EBF3 VWA5A ENPEP	5.26e-04	23	182	3	MM945
Coexpression	LIM_MAMMARY_STEM_CELL_UP	ARHGAP24 EBF3 NT5E TTYH2 SVEP1 PRDM1 TGFBR3 DST P3H1 C1QTNF4 TAGLN	5.51e-04	479	182	11	M2573
Coexpression	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN	EMC1 ZMPSTE24 SRSF4 GRK2 ZNF770 DAAM1 PADI2 GAREM1	5.67e-04	266	182	8	M1845
Coexpression	PAL_PRMT5_TARGETS_UP	SRSF6 SLC35A1 MET TARDBP PTPRK HSPA4 KIF11	5.79e-04	204	182	7	M10688
Coexpression	GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_UP	TTYH2 SRF NPHP3 ENPEP GABRA6 WDR72	5.81e-04	147	182	6	M2989
Coexpression	HEVNER_CORTEX_APICAL_AND_BASAL_INTERMEDIATE_PROGENITOR_CELLS	KDM4C PTPRK KAT6B SORL1	5.82e-04	55	182	4	MM397
Coexpression	LIAN_LIPA_TARGETS_6M	ACP5 SLFN12 CD84 DST RP1	5.88e-04	97	182	5	MM1016
Coexpression	LIM_MAMMARY_STEM_CELL_UP	ARHGAP24 EBF3 NT5E TTYH2 SVEP1 PRDM1 TGFBR3 DST P3H1 C1QTNF4 TAGLN	5.90e-04	483	182	11	MM1082
Coexpression	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	NT5E NLRP1 MSH3 EBF1 TGFBR3 DST HMCN1 TAGLN VCL	6.10e-04	337	182	9	M13206
Coexpression	BUSSLINGER_GASTRIC_G_CELLS	MAP1B DSP BPTF DST SORL1	6.16e-04	98	182	5	M40018
Coexpression	BENPORATH_CYCLING_GENES	USP53 DSP POLA1 HJURP SRF G2E3 ACYP1 SELENON USP16 MET HSPA1L VCL KIF11	6.29e-04	648	182	13	M8156
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B ABCC9 EBF1 SVEP1 MAP3K5 DST ROBO1 DAAM1 TAGLN VCL COL1A2	6.03e-10	194	185	11	90efdbd7f1c85fd7fd622b10340250b1d8fc1197
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B ABCC9 EBF1 SVEP1 MAP3K5 DST ROBO1 DAAM1 TAGLN VCL COL1A2	6.03e-10	194	185	11	df82cce5ebeb73740b02cf816c6df82253cfd566
ToppCell	LA\|World / Chamber and Cluster_Paper	PRUNE2 MAP1B RTN4 EBF1 SVEP1 TGFBR3 ROBO1 C3 TAGLN COL1A2	8.81e-09	193	185	10	d4bf89437216baf489ea0239136dcedf3b6714af
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	PRUNE2 MAP1A MAP1B ABCC9 TGFBR3 FAT1 DST TAGLN VCL COL1A2	1.24e-08	200	185	10	593bf6a7c557437db9a9249a5058a46014179ef6
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PRUNE2 MAP1B ABCC9 TGFBR3 FAT1 DST TAGLN ATP1A4 VCL COL1A2	1.24e-08	200	185	10	c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PRUNE2 DCHS2 DNAH7 DSCAML1 MET TMEM130 FAT1 TENM4 WDR72	6.13e-08	178	185	9	544379f5a6145429762258d426b876bb36c112f5
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 MAP1B KALRN ABCC9 EBF1 SVEP1 TAGLN VCL COL1A2	7.41e-08	182	185	9	44764676ed3f51ba171ce63f669390392fa50a43
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 MAP1B KALRN ABCC9 EBF1 SVEP1 TAGLN VCL COL1A2	7.41e-08	182	185	9	d82f59a3f930a840dde27dc6ab024f227a26d446
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KALRN ADGRV1 DSCAML1 FAT1 TENM4 HMCN1 PTPRQ ROBO1 ATP1A4	8.14e-08	184	185	9	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KALRN ADGRV1 DSCAML1 FAT1 TENM4 HMCN1 PTPRQ ROBO1 ATP1A4	8.14e-08	184	185	9	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KALRN ADGRV1 DSCAML1 FAT1 TENM4 HMCN1 PTPRQ ROBO1 ATP1A4	8.14e-08	184	185	9	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	E16.5-samps-Mesenchymal-Myofibroblast\|E16.5-samps / Age Group, Lineage, Cell class and subclass	MAP1B NT5E TTYH2 TGFBR3 TENM4 DST ROBO1 TAGLN COL1A2	8.93e-08	186	185	9	e044b3428b7eacfdc72d0f57cdabaa1de04c74cd
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 ARHGAP24 EPHA6 ADGRV1 DSCAML1 MET TMEM130 RP1 WDR72	1.07e-07	190	185	9	1cf023e3c6924d6a06f353d4b62444b6f2fee8a7
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 ARHGAP24 EPHA6 ADGRV1 DSCAML1 MET TMEM130 RP1 WDR72	1.07e-07	190	185	9	59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN ABCC9 EBF1 SVEP1 MAP3K5 TGFBR3 DAAM1 VCL COL1A2	1.34e-07	195	185	9	803f714d91f2d97ecbee8c15a5139fd9310f66c7
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN ABCC9 EBF1 SVEP1 MAP3K5 TGFBR3 DAAM1 VCL COL1A2	1.34e-07	195	185	9	4f70157d42a16ff0259bc24a62803c4df4285c44
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B ABCC9 EBF1 SVEP1 MAP3K5 DAAM1 TAGLN VCL COL1A2	1.46e-07	197	185	9	80e153790cef37b743e22a7370ff5b3a6abf147d
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PRUNE2 MAP1B TGFBR3 FAT1 DST TAGLN ATP1A4 VCL COL1A2	1.59e-07	199	185	9	e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	USP53 MAP1B CCDC186 ABCC9 USP16 BPTF DST PRRC2C SECISBP2	1.59e-07	199	185	9	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PRUNE2 MAP1B ABCC9 TGFBR3 FAT1 TAGLN ATP1A4 VCL COL1A2	1.66e-07	200	185	9	f599e4b051ac3dad11ad437e98dc8ea6754cca53
ToppCell	Hematolymphoid-Microglia-TYROBP--\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	CYBB USP53 ARHGAP24 MED13L WDFY2 MAP3K5 PTPRJ C3 SORL1	1.66e-07	200	185	9	dc344b3ec51d506952e38f0b3a7795d65f9dd4eb
ToppCell	Hematolymphoid-Microglia\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	CYBB USP53 ARHGAP24 MED13L WDFY2 MAP3K5 PTPRJ C3 SORL1	1.66e-07	200	185	9	21bcca3b670fe9bac034aef2275d3de4a9a73e2b
ToppCell	Hematolymphoid-Microglia-TYROBP\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	CYBB USP53 ARHGAP24 MED13L WDFY2 MAP3K5 PTPRJ C3 SORL1	1.66e-07	200	185	9	33036d21c1c82109284473a515c4f890b33fdd5c
ToppCell	Hematolymphoid-Microglia-TYROBP----L1-3\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	CYBB USP53 ARHGAP24 MED13L WDFY2 MAP3K5 PTPRJ C3 SORL1	1.66e-07	200	185	9	a20dce14f94777687aad57d6fbe3258ad376f63f
ToppCell	Hematolymphoid-Microglia-TYROBP-\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	CYBB USP53 ARHGAP24 MED13L WDFY2 MAP3K5 PTPRJ C3 SORL1	1.66e-07	200	185	9	3bba5219453322198e8fdb0921d5f8c403598751
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PRUNE2 MAP1B TGFBR3 FAT1 DST TAGLN ATP1A4 VCL COL1A2	1.66e-07	200	185	9	08bf8c00eee6468215edb3611296bfc8784c4d56
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PRUNE2 MAP1B ABCC9 TGFBR3 FAT1 TAGLN ATP1A4 VCL COL1A2	1.66e-07	200	185	9	67dcbd86fbc79fd585d0793f979e4aac100326c9
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	PRUNE2 MAP1A MAP1B TGFBR3 FAT1 DST TAGLN VCL COL1A2	1.66e-07	200	185	9	02cae2c296a13ad4cbb53bca7a86d64629d67d66
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PRUNE2 MAP1B TGFBR3 FAT1 DST TAGLN ATP1A4 VCL COL1A2	1.66e-07	200	185	9	dcdaec3ca3a3024dc1b8788c417003f84c2bffdc
ToppCell	Hematolymphoid-Microglia-TYROBP---\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	CYBB USP53 ARHGAP24 MED13L WDFY2 MAP3K5 PTPRJ C3 SORL1	1.66e-07	200	185	9	a8646d0fca99f10827c2d2a12e584660ef7155f1
ToppCell	LPS_only-Mesenchymal_myocytic\|LPS_only / Treatment groups by lineage, cell group, cell type	MAP1A MAP1B ABCC9 TGFBR3 FAT1 TAGLN ATP1A4 VCL COL1A2	1.66e-07	200	185	9	8bc9923f82bfb836e2f524204c92050edeae8ca5
ToppCell	P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ARHGAP24 ADGRV1 SVEP1 TENM4 TAGLN ENPEP SORL1 COL1A2	5.83e-07	170	185	8	ba4ba66b624089ed50a9083176386c7941b4c7a3
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MAP1B EBF3 EBF1 SVEP1 TGFBR3 TENM4 ROBO1 COL1A2	1.10e-06	185	185	8	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CYBB ADGRV1 MED13L TENM4 GRK2 PRRC2C NUFIP2 KDM7A	1.15e-06	186	185	8	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	EPHA6 SVEP1 TGFBR3 TENM4 DST HMCN1 ROBO1 COL1A2	1.20e-06	187	185	8	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	Adult-Epithelial-club_cell-D231\|Adult / Lineage, Cell type, age group and donor	DSP NT5E ADGRV1 PLEKHG4B MET TMEM130 FAT1 GAREM1	1.20e-06	187	185	8	ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	USP53 PRUNE2 MAP1B KALRN EBF1 DST TAGLN COL1A2	1.20e-06	187	185	8	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 MAP1B ABCC9 EBF1 TGFBR3 FAT1 TAGLN COL1A2	1.29e-06	189	185	8	7ab1cfc1657277858339f7258a0c4ae9cb42fdf8
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP24 ADGRV1 DSCAML1 MET DST PTPRJ RP1 VCL	1.29e-06	189	185	8	8c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP24 ADGRV1 DSCAML1 MET DST PTPRJ RP1 VCL	1.29e-06	189	185	8	5d902a4660a27548764bf04c6de152b565da835c
ToppCell	Adult-Epithelial-club_cell\|Adult / Lineage, Cell type, age group and donor	DSP NT5E ADGRV1 PLEKHG4B MET TMEM130 FAT1 GAREM1	1.35e-06	190	185	8	756bff697d30aec56c0ebfca94295f084a15bf37
ToppCell	Mesenchymal-vascular_smooth_muscle_cell\|World / Lineage, Cell type, age group and donor	MAP1B KALRN EBF1 FAT1 HMCN1 TAGLN ENPEP COL1A2	1.40e-06	191	185	8	fd89fbc62aa1c73e0f659991e3bd726a0c97bd68
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	HSPD1 DSP MED13L BPTF PTPRK ROBO1 DAAM1 HSPA4	1.46e-06	192	185	8	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 MAP1B ABCC9 EBF1 TGFBR3 FAT1 TAGLN COL1A2	1.46e-06	192	185	8	992d08092edbc68c47b945deb8708379738c239a
ToppCell	Epithelial-club_cell\|World / Lineage, Cell type, age group and donor	ADGRV1 PLEKHG4B MET TMEM130 FAT1 PTPRK RP1 GAREM1	1.51e-06	193	185	8	2bdd09004fa433550958ec42ba4b06271a4aaf7c
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	MAP1B TGFBR3 TENM4 DST HMCN1 PTPRK ROBO1 COL1A2	1.51e-06	193	185	8	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	HSPD1 DSP MED13L BPTF PRRC2C ROBO1 PLCG2 HSPA4	1.51e-06	193	185	8	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	G2E3 RO60 MSH3 ADGRV1 BPTF ATP11B PTPRK ZNF770	1.51e-06	193	185	8	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	metastatic_Brain-Fibroblasts-Pericytes\|metastatic_Brain / Location, Cell class and cell subclass	MAP1A MAP1B ABCC9 EBF1 FGF1 TAGLN ENPEP COL1A2	1.57e-06	194	185	8	d1889a3e22d5b88461c81ec3ea0e74bb9bf63e60
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 MET FAT1 PTPRJ PTPRK ENPEP GAREM1 WDR72	1.57e-06	194	185	8	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	COVID-19-Heart-Fib_1\|Heart / Disease (COVID-19 only), tissue and cell type	ARHGAP24 EBF1 SVEP1 TGFBR3 TENM4 ROBO1 C3 COL1A2	1.64e-06	195	185	8	f423baa36ac7cdc383c033e35a7d17e6bf913323
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B KALRN ABCC9 EBF1 SVEP1 TAGLN VCL COL1A2	1.64e-06	195	185	8	dd281a249854800f737dc22e0f375f66dfb5cf5f
ToppCell	RA-02._Fibroblast_II\|RA / Chamber and Cluster_Paper	USP53 SYN3 EBF1 SVEP1 TGFBR3 ROBO1 DAAM1 COL1A2	1.64e-06	195	185	8	6a02ebbeb3199447ddce64d92d8809436e040eba
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	USP53 SYN3 EBF1 SVEP1 DST HMCN1 ROBO1 COL1A2	1.64e-06	195	185	8	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B ABCC9 EBF1 SVEP1 MAP3K5 DST TAGLN COL1A2	1.64e-06	195	185	8	d8ebb94f30d4a655d6b29dd6a3076be2403d2356
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARHGAP24 MAP1B ANXA5 TGFBR3 TENM4 ROBO1 TAGLN COL1A2	1.64e-06	195	185	8	2514c1f23424b5fc664d326d31ffd22bafe74ef8
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B KALRN ABCC9 EBF1 SVEP1 TAGLN VCL COL1A2	1.64e-06	195	185	8	49c99553629cdd83ee56a2e508d5bc8d34b8507b
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	USP53 SYN3 SVEP1 DST HMCN1 ROBO1 ENPEP COL1A2	1.64e-06	195	185	8	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARHGAP24 MAP1B ANXA5 TGFBR3 TENM4 ROBO1 TAGLN COL1A2	1.70e-06	196	185	8	e4d04e1f82779e8afd4e32bbe38d1d3f6f64ab50
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARHGAP24 MAP1B ANXA5 TGFBR3 TENM4 ROBO1 TAGLN COL1A2	1.70e-06	196	185	8	f0fd7db22985d2bc84dc8bcbdb2d552e280121dd
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC9 EBF1 SVEP1 MAP3K5 DAAM1 TAGLN VCL COL1A2	1.70e-06	196	185	8	2b36b9a40fe415917afccff99ad9c3474e087d0d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B KALRN ABCC9 EBF1 SVEP1 HMCN1 TAGLN COL1A2	1.70e-06	196	185	8	fa445f4240c521cf04eb2e2f79a5c55fda31209a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B KALRN ABCC9 EBF1 SVEP1 HMCN1 TAGLN COL1A2	1.70e-06	196	185	8	802f61e78a9a1030a86c4a980c398a73cd4d1574
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B KALRN ABCC9 EBF1 SVEP1 TAGLN VCL COL1A2	1.70e-06	196	185	8	3a6c942e2907aa07b5e12dbf9019d18f7bfca507
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B KALRN ABCC9 EBF1 SVEP1 TAGLN VCL COL1A2	1.70e-06	196	185	8	bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	USP53 SYN3 EBF1 SVEP1 DST HMCN1 ROBO1 COL1A2	1.70e-06	196	185	8	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B KALRN ABCC9 EBF1 SVEP1 TAGLN VCL COL1A2	1.77e-06	197	185	8	09946ee8dfb15a2a32da06e5b331f3277ee934f4
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARHGAP24 MAP1B ANXA5 TENM4 HMCN1 ROBO1 TAGLN COL1A2	1.77e-06	197	185	8	26475b9e4d6bfc0ae818dea13d139888ed7e92f1
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DCHS2 MAP1B NDST4 SVEP1 TENM4 HMCN1 ROBO1 COL1A2	1.77e-06	197	185	8	44673c38384453207871d3fd8e8ba9093cc06bc5
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARHGAP24 MAP1B ANXA5 TENM4 HMCN1 ROBO1 TAGLN COL1A2	1.77e-06	197	185	8	155e63b33302a87393ace699b2f6d73abe9c5763
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	KIF13B ARHGAP24 PSMA1 TENM4 HMCN1 ROBO1 DAAM1 COL1A2	1.77e-06	197	185	8	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARHGAP24 MAP1B ANXA5 TENM4 HMCN1 ROBO1 TAGLN COL1A2	1.83e-06	198	185	8	a4005a49cf6709b543994ceb51ecd5dc46197fa9
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B KALRN ABCC9 EBF1 SVEP1 TAGLN VCL COL1A2	1.83e-06	198	185	8	79576525a10ed3e3a9d1608077cd16ecda23376f
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARHGAP24 MAP1B ANXA5 TENM4 HMCN1 ROBO1 TAGLN COL1A2	1.83e-06	198	185	8	a699b365d3b6149f13f02b2e2ae9b6fdce761848
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	USP53 SYN3 EBF1 SVEP1 DST HMCN1 ROBO1 COL1A2	1.83e-06	198	185	8	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	COVID-19-kidney-Fibroblast-1\|kidney / Disease (COVID-19 only), tissue and cell type	MAP1B KALRN ABCC9 EBF1 SVEP1 DST TAGLN COL1A2	1.90e-06	199	185	8	9503646ff1ad248181146ce767e9d12e882ec3bd
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	PRUNE2 MAP1B TGFBR3 FAT1 TAGLN ATP1A4 VCL COL1A2	1.98e-06	200	185	8	c5e051f1aac8dda376c342a9932785a23450e073
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MAP1B ABCC9 FAM81A FAT1 TAGLN ATP1A4 VCL COL1A2	1.98e-06	200	185	8	b5b5a32925f225610fe25a021a742d6397162863
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MAP1A MAP1B FAM81A FAT1 TAGLN ATP1A4 VCL COL1A2	1.98e-06	200	185	8	9169a9ec8e9ab95d90a64c5a19ac666a5cf82313
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ARHGAP24 MAP1B ABCC9 EBF1 FAT1 TAGLN VCL COL1A2	1.98e-06	200	185	8	d2fcd3bd7c3223875f027eeb48ff621192a5f242
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	PRUNE2 TGFBR3 MET FAT1 TAGLN ATP1A4 VCL COL1A2	1.98e-06	200	185	8	9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1
ToppCell	(6)_Stroma\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	MAP1A MAP1B ABCC9 EBF1 SVEP1 C3 ENPEP COL1A2	1.98e-06	200	185	8	f0818821c495022569aef2c1886d9f2446dc027e
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MAP1B ABCC9 EBF1 FAT1 TAGLN ATP1A4 VCL COL1A2	1.98e-06	200	185	8	b22cae282591d8dead9869c2adbb9632615f50f7
ToppCell	(6)_Stroma\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	MAP1A MAP1B ABCC9 EBF1 SVEP1 C3 ENPEP COL1A2	1.98e-06	200	185	8	f9baef67dde62f1c161a9408a78f635ea70ea9d3
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PRUNE2 MAP1B TGFBR3 FAT1 TAGLN ATP1A4 VCL COL1A2	1.98e-06	200	185	8	8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	EBF1 SVEP1 TGFBR3 DST HMCN1 ROBO1 ENPEP COL1A2	1.98e-06	200	185	8	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	LPS_IL1RA-Mesenchymal_myocytic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MAP1B ABCC9 TGFBR3 FAT1 TAGLN ATP1A4 VCL COL1A2	1.98e-06	200	185	8	77631c471cc5d453a749784f838cfa6408caf09b
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-Z\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ARHGAP24 ABCC9 ATP9B CD84 SAMD9L C3 SORL1	2.54e-06	145	185	7	9743d68ba8bfef56fd9a979ab357c0e287eb5ae2
ToppCell	TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma\|TCGA-Uterus / Sample_Type by Project: Shred V9	POGK CCDC186 PSMA1 RO60 DST PLCG2 ATP1A4	3.32e-06	151	185	7	2810bfa01bd3016aeba29735eb4a9284792e8aac
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TRAF6 ARHGAP24 ZFP57 FAT1 HMCN1 KCNJ2 CPNE7	3.62e-06	153	185	7	9c6fce56300ba5053efda59a438d63a808c497c0
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1A MAP1B ABCC9 EBF1 TAGLN ENPEP COL1A2	6.45e-06	167	185	7	bb53a478b5d821d6d82c15bc4ed075b67682457c
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1A MAP1B ABCC9 EBF1 TAGLN ENPEP COL1A2	6.45e-06	167	185	7	e228b8373ffd4436e6b944e26d0fadf3ac289b21
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1A MAP1B ABCC9 EBF1 TAGLN ENPEP COL1A2	6.45e-06	167	185	7	7cb1b11e8e24a10115e46ffbb74889e672a7a026
ToppCell	COVID-19-kidney-PEC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PRUNE2 DNAH7 DSCAML1 MET TMEM130 FAT1 WDR72	6.71e-06	168	185	7	a086c306be430adf0632ba53e98cd8014d2de330
ToppCell	Adult-Mesenchymal-chondrocyte-D175\|Adult / Lineage, Cell type, age group and donor	EPHA6 MAP1A MAP1B NT5E EBF1 POLR1E COL1A2	6.71e-06	168	185	7	14071b961c9bdb54a8259b12a88237b802cbde36
ToppCell	facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1A KALRN G2E3 FAM81A FGF1 TAGLN CKMT1A	7.53e-06	171	185	7	b54d9d6b03c9c6f28a71cf2ed2bfa9a335bba949
ToppCell	facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1A KALRN G2E3 FAM81A FGF1 TAGLN CKMT1A	7.53e-06	171	185	7	9d825a2e799421af4f2cf4f4dc8e239b5d00476d
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	USP53 EBF3 EBF1 SVEP1 TGFBR3 C3 COL1A2	7.82e-06	172	185	7	e37c0b5b547a7345179ab258dd2141fec7064c17
ToppCell	facs-Lung-ENDOMUCIN-18m-Myeloid\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB NLRP1 CD84 GRK2 PLCG2 PADI2 SORL1	7.82e-06	172	185	7	0457ccc18697aaec44b7c30ae157aae8f48d8785
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TGFBR3 TMEM130 DST PTPRQ FGF1 ROBO1 ENPEP	7.82e-06	172	185	7	6c17a1e586a72d1bd80c20c06370429c61dc9f85
Drug	geldanamycin	HSPD1 MAP1B CCDC186 SRPRA RO60 ACTR2 MAP3K5 ZNF518A CUL5 MET DST ATP11B PRRC2C RBAK ZNF770 HSPA4	5.41e-08	371	182	16	ctd:C001277
Drug	Hymecromone [90-33-5]; Down 200; 22.8uM; HL60; HT_HG-U133A	USP53 CYP3A4 CCDC186 NLRP1 ATP9B H6PD SUV39H2 GRK2 CLEC4A MIOS ENPEP COL1A2	7.02e-08	198	182	12	3045_DN
Drug	lead nitrate	NT5E ACP5 H6PD ACYP2 FGF1 HSPA4	3.60e-06	52	182	6	CID000024924
Drug	N-acetyl-dl-alanine	PSMA1 NLRP1 ACYP1 ACYP2 FGF1	3.74e-06	30	182	5	CID000007345
Drug	Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; PC3; HT_HG-U133A	EMC1 CCDC186 NLRP1 SUV39H2 DNAH7 MET VWA5A PLA2G6 HSPA4 CPNE7	3.85e-06	194	182	10	3779_DN
Drug	Moxalactam disodium salt [64953-12-4]; Up 200; 7uM; PC3; HT_HG-U133A	MYH7 TRPC7 KALRN ABCC9 SVEP1 MET KCNA2 CLEC4A FGF1 ENPEP	4.82e-06	199	182	10	4648_UP
Drug	Lidoflazine [3416-26-0]; Down 200; 8.2uM; MCF7; HT_HG-U133A	SRF SRPRA RO60 CUL5 MET GRK2 P3H1 PC RHOT1 TBCD	5.04e-06	200	182	10	6278_DN
Drug	Magnetite Nanoparticles	CYBB HSPD1 KDM4C POLA1 PSMA1 RTN4 ACP5 SRF G2E3 RO60 LCK USP16 SUV39H2 MAP3K5 ZNF518A PRDM1 TARDBP SAMD9L FGF1 C3 KDM7A DAAM1 PADI2 HSPA4 USP47 KIF11 SORL1	5.76e-06	1310	182	27	ctd:D058185
Drug	NSC618487	HYAL4 EPHA6 DIABLO POGK ANXA5 PIK3R3 NLRP1 LCK USP16 MAP3K5 KCNA2 KCNA3 GRK2 KCNJ2 AGK FGF1 PLA2G6 PLCG2 ENPEP HSPA4 VCL COL1A2	5.82e-06	933	182	22	CID000005279
Drug	bis(2-pyridylmethyl)amine	PSMA1 ANXA5 DST	9.87e-06	6	182	3	CID000073759
Drug	exemestane	KIF13B CYP3A4 EBF1 FAT1 PLCG2	2.32e-05	43	182	5	CID000060198
Drug	Dihydroergotamine tartrate [5989-77-5]; Down 200; 3uM; PC3; HT_HG-U133A	TRAF6 MAP1A SUN1 MAP3K5 FBXO9 BTBD7 PLCG2 PC COG4	2.52e-05	192	182	9	2081_DN
Drug	Succimer	CYBB KDM4C POLA1 PSMA1 RTN4 ACP5 G2E3 RO60 LCK USP16 SUV39H2 MAP3K5 ZNF518A PRDM1 TARDBP SAMD9L FGF1 C3 KDM7A DAAM1 PADI2 HSPA4 USP47 KIF11 SORL1	2.65e-05	1264	182	25	ctd:D004113
Drug	E-4-H	HSPD1 ACP5 NLRP1	2.73e-05	8	182	3	CID005282031
Drug	trifluoperazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A	NLRP1 MET PPP2R5A BPI CLEC4A KCNJ2 FGF1 ENPEP GAREM1	2.85e-05	195	182	9	6183_UP
Drug	propidium iodide	HSPD1 DIABLO ANXA5 NLRP1 MET VWA5A PLA2G6 HSPA4	3.00e-05	151	182	8	CID000004939
Drug	Tenoxicam [59804-37-4]; Down 200; 11.8uM; HL60; HT_HG-U133A	CYP3A4 CCDC186 SUN1 NLRP1 RO60 SULT1B1 BPI BTBD7 TRMT61A	3.09e-05	197	182	9	2501_DN
Drug	Methylhydantoin-5-(L) [40856-73-3]; Up 200; 35uM; HL60; HT_HG-U133A	PRUNE2 IFT140 TRPC7 IMPG1 MAP1B KALRN NLRP1 LCK DNAH7	3.09e-05	197	182	9	3040_UP
Drug	AC1MRR4B	DIABLO ANXA5 SLC35A1 BPTF AGK PLA2G6 RP1 ENPEP CKMT1A	3.34e-05	199	182	9	CID003522484
Drug	Felbinac [5728-52-9]; Up 200; 18.8uM; HL60; HT_HG-U133A	MYH7 TRPC7 IMPG1 KALRN SUN1 RBP3 CFHR5 SVEP1 MET	3.34e-05	199	182	9	3061_UP
Drug	rapamycin, Streptomyces hygroscepicus; Up 200; 0.1uM; MCF7; HT_HG-U133A	KALRN CYP3A4 SRPRA RO60 DNAH7 KCNA3 PLA2G6 CPNE7 COL1A2	3.34e-05	199	182	9	5927_UP
Drug	Austricine [10180-88-8]; Down 200; 14.2uM; HL60; HT_HG-U133A	TRAF2 CYP3A4 CCDC186 PIK3R3 SUN1 CD84 BTBD7 TAGLN TBCD	3.47e-05	200	182	9	2157_DN
Drug	glycerol	HSPD1 POLA1 ACP5 SUN1 ADGRV1 MCCC1 H6PD ACYP1 ACYP2 AHSA1 BPTF POLR3B FGF1 PLA2G6 C3 DAAM1 PC HSPA4 CKMT1A	3.86e-05	829	182	19	CID000000753
Drug	Gold	HSPD1 ZMPSTE24 ANXA5 RTN4 G2E3 RO60 USP16 FGF1 PLA2G6 C3 HSPA4 VCL COL1A2	4.73e-05	432	182	13	ctd:D006046
Drug	N-Aceyl-L-Carnosine	PSMA1 ANXA5 NLRP1	5.79e-05	10	182	3	CID000091814
Disease	Cardiomyopathies	HSPD1 MYH7 DSP ABCC9 MAP3K5 GRK2 VCL MYBPC3	1.30e-06	130	178	8	C0878544
Disease	Cardiomyopathy	MYH7 DSP ABCC9 VCL MYBPC3	9.43e-06	47	178	5	cv:C0878544
Disease	Hypertrophic Cardiomyopathy	HSPD1 MYH7 DSP VCL MYBPC3	2.45e-05	57	178	5	C0007194
Disease	photoreceptor cell layer thickness measurement	IMPG1 MAP1B SUN1 RBP3 PRDM1 DST WDR72	3.38e-05	148	178	7	EFO_0803370
Disease	Primary dilated cardiomyopathy	MYH7 ABCC9 VCL MYBPC3	5.15e-05	34	178	4	cv:C0007193
Disease	Autoinflammatory disorder	POLA1 ACP5 NLRP1 PLCG2	5.79e-05	35	178	4	C3860213
Disease	intrinsic cardiomyopathy (is_marker_for)	MYH7 TRAF6	1.08e-04	3	178	2	DOID:0060036 (is_marker_for)
Disease	hypothyroidism (biomarker_via_orthology)	MYH7 MAP1A MAP1B ANXA5 COL1A2	1.26e-04	80	178	5	DOID:1459 (biomarker_via_orthology)
Disease	dilated cardiomyopathy (is_implicated_in)	MYH7 DSP ABCC9 VCL	1.31e-04	43	178	4	DOID:12930 (is_implicated_in)
Disease	serum gamma-glutamyl transferase measurement	MAP1A SYT12 KALRN PIK3R3 NLRP1 EBF1 USP16 WDFY2 MET BPTF WWC2 TENM4 ROBO1 C3 RP1 HSPA4	1.43e-04	914	178	16	EFO_0004532
Disease	Familial dilated cardiomyopathy	MYH7 ABCC9 VCL MYBPC3	1.44e-04	44	178	4	C0340427
Disease	hypertrophic cardiomyopathy (is_implicated_in)	MYH7 VCL MYBPC3	3.05e-04	22	178	3	DOID:11984 (is_implicated_in)
Disease	Primary familial hypertrophic cardiomyopathy	MYH7 VCL MYBPC3	3.05e-04	22	178	3	cv:C0949658
Disease	urinary pH measurement	KALRN WDR72	3.58e-04	5	178	2	EFO_0010136
Disease	Osteogenesis imperfecta, dominant perinatal lethal	P3H1 COL1A2	3.58e-04	5	178	2	C0268358
Disease	Lobstein Disease	P3H1 COL1A2	3.58e-04	5	178	2	C0023931
Disease	Hypertrophic obstructive cardiomyopathy	HSPD1 MYH7 MYBPC3	4.50e-04	25	178	3	C4551472
Disease	Congenital myopathy with fiber type disproportion	MYH7 SELENON	5.34e-04	6	178	2	cv:C0546264
Disease	Atrial fibrillation	ABCC9 KCNJ2	5.34e-04	6	178	2	cv:C0004238
Disease	Idiopathic hypertrophic subaortic stenosis	MYH7 MYBPC3	7.45e-04	7	178	2	C0700053
Disease	Obstructive asymmetric septal hypertrophy	MYH7 MYBPC3	7.45e-04	7	178	2	C0597124
Disease	Parkinson's disease (biomarker_via_orthology)	HSPD1 GRK2 HSPA4	7.77e-04	30	178	3	DOID:14330 (biomarker_via_orthology)
Disease	Primary familial dilated cardiomyopathy	MYH7 ABCC9 VCL	7.77e-04	30	178	3	cv:C0340427
Disease	Cardiomyopathies, Primary	HSPD1 MAP3K5 GRK2 MYBPC3	8.15e-04	69	178	4	C0033141
Disease	Myocardial Diseases, Secondary	HSPD1 MAP3K5 GRK2 MYBPC3	8.15e-04	69	178	4	C0036529
Disease	rheumatoid arthritis (is_marker_for)	HSPD1 GRK2 C3 HSPA4	8.15e-04	69	178	4	DOID:7148 (is_marker_for)
Disease	Diabetes Mellitus	CYBB ZFP57 MAP3K5	9.41e-04	32	178	3	C0011849
Disease	HDL cholesterol change measurement, response to simvastatin, response to fenofibrate	MSH3 TGFBR3	9.89e-04	8	178	2	EFO_0007805, GO_1901557, GO_1903491
Disease	Sudden Cardiac Arrest	DSP MYBPC3	9.89e-04	8	178	2	C1720824
Disease	Sudden Cardiac Death	DSP MYBPC3	9.89e-04	8	178	2	C0085298
Disease	macula measurement	DCHS2 RBP3 BPTF FAT1 SORL1 WDR72	1.04e-03	189	178	6	EFO_0008375
Disease	Middle Cerebral Artery Embolus	HSPD1 C3 GABRA6	1.13e-03	34	178	3	C0751845
Disease	Embolic Infarction, Middle Cerebral Artery	HSPD1 C3 GABRA6	1.13e-03	34	178	3	C0751847
Disease	Left Middle Cerebral Artery Infarction	HSPD1 C3 GABRA6	1.13e-03	34	178	3	C0751846
Disease	Right Middle Cerebral Artery Infarction	HSPD1 C3 GABRA6	1.13e-03	34	178	3	C0751849
Disease	Thrombotic Infarction, Middle Cerebral Artery	HSPD1 C3 GABRA6	1.13e-03	34	178	3	C0751848
Disease	Middle Cerebral Artery Occlusion	HSPD1 C3 GABRA6	1.13e-03	34	178	3	C0740391
Disease	Infarction, Middle Cerebral Artery	HSPD1 C3 GABRA6	1.13e-03	34	178	3	C0740392
Disease	Middle Cerebral Artery Thrombosis	HSPD1 C3 GABRA6	1.13e-03	34	178	3	C0740376
Disease	Middle Cerebral Artery Syndrome	HSPD1 C3 GABRA6	1.13e-03	34	178	3	C0238281
Disease	Cardiomyopathy, Hypertrophic, Familial	MYH7 MYBPC3	1.27e-03	9	178	2	C0949658
Disease	C3 glomerulopathy	CFHR5 C3	1.27e-03	9	178	2	C4087273
Disease	electrocardiography	ARHGAP24 EBF1 KCNA2 KCNA3 KCNJ2 NUFIP2 MICU2 KAT6B VCL MYBPC3	1.49e-03	530	178	10	EFO_0004327
Disease	PR segment	ARHGAP24 MICU2	1.58e-03	10	178	2	EFO_0005095
Disease	sleep time	ARMC3 EBF3	1.58e-03	10	178	2	EFO_0005274
Disease	Osteogenesis imperfecta type III (disorder)	P3H1 COL1A2	1.92e-03	11	178	2	C0268362
Disease	Tachycardia, Ventricular	ABCC9 KCNJ2	1.92e-03	11	178	2	C0042514
Disease	thrombin generation potential measurement	PTPRJ MYBPC3	1.92e-03	11	178	2	EFO_0005538
Disease	Shortened QT interval	ABCC9 KCNJ2	1.92e-03	11	178	2	C0151879
Disease	liver benign neoplasm (biomarker_via_orthology)	MET HSPA4	1.92e-03	11	178	2	DOID:916 (biomarker_via_orthology)
Disease	Bipolar I disorder	TRPC7 KAT6B	1.92e-03	11	178	2	C0853193
Disease	emphysema imaging measurement	KIF16B OR8B3 PTPRK ZNF770 OR8B2	1.96e-03	146	178	5	EFO_0007626
Disease	autistic disorder (is_implicated_in)	HSPD1 KDM4C MET	2.08e-03	42	178	3	DOID:12849 (is_implicated_in)
Disease	systemic lupus erythematosus (implicated_via_orthology)	CYBB RO60 PRDM1	2.23e-03	43	178	3	DOID:9074 (implicated_via_orthology)
Disease	progression free survival, urinary bladder cancer	IFT140 TENM4	2.30e-03	12	178	2	EFO_0004920, MONDO_0001187
Disease	hypertension (biomarker_via_orthology)	CYBB HSPD1 MYH7 ABCC9 GRK2 C3	2.63e-03	227	178	6	DOID:10763 (biomarker_via_orthology)
Disease	Liver Cirrhosis, Experimental	CYBB PRUNE2 NT5E ANXA5 RTN4 ACP5 FAT1 FBXO9 CLEC4A PC ENPEP COL1A2	2.69e-03	774	178	12	C0023893
Disease	Autosomal Dominant Myotubular Myopathy	MYH7 SELENON	2.70e-03	13	178	2	C3661489
Disease	Centronuclear myopathy	MYH7 SELENON	2.70e-03	13	178	2	C0175709
Disease	X-linked centronuclear myopathy	MYH7 SELENON	2.70e-03	13	178	2	C0410203
Disease	Osteogenesis Imperfecta	P3H1 COL1A2	2.70e-03	13	178	2	C0029434
Disease	Myopathy, Centronuclear, 1	MYH7 SELENON	2.70e-03	13	178	2	C4551952
Disease	Congenital Structural Myopathy	MYH7 SELENON	2.70e-03	13	178	2	C0752282
Disease	monocyte count	KALRN EBF1 ADGRV1 MED13L WDFY2 MAP3K5 CD84 TGFBR3 KCNA2 KCNA3 BPI NUFIP2 C3 ATP1A4 HSPA4 SORL1 MYBPC3	2.73e-03	1320	178	17	EFO_0005091
Disease	Atrial Fibrillation	MYH7 SUN1 ABCC9 KCNJ2 SORL1	2.92e-03	160	178	5	C0004238
Disease	myocardial infarction (biomarker_via_orthology)	CYBB HSPD1 MYH7 ANXA5 C3	2.92e-03	160	178	5	DOID:5844 (biomarker_via_orthology)
Disease	triglyceride measurement, alcohol drinking	EBF1 PLA2G6 HSPA4 MYBPC3	3.09e-03	99	178	4	EFO_0004329, EFO_0004530
Disease	Myopathy, Centronuclear, Autosomal Dominant	MYH7 SELENON	3.14e-03	14	178	2	C1834558
Disease	Tubular Aggregate Myopathy	MYH7 SELENON	3.14e-03	14	178	2	C0410207
Disease	familial atrial fibrillation (is_implicated_in)	ABCC9 KCNJ2	3.14e-03	14	178	2	DOID:0050650 (is_implicated_in)
Disease	Left ventricular noncompaction	MYH7 MYBPC3	3.14e-03	14	178	2	C1960469
Disease	PR interval	KIF13B MYH7 ARHGAP24 KALRN SUN1 FAT1 MICU2 GAREM1 COL1A2	3.25e-03	495	178	9	EFO_0004462
Disease	triglyceride measurement, alcohol consumption measurement	EBF1 PLA2G6 HSPA4 MYBPC3	3.32e-03	101	178	4	EFO_0004530, EFO_0007878
Disease	chenodeoxycholate measurement	HMCN1 SLC22A20P	3.61e-03	15	178	2	EFO_0010471
Disease	Autosomal Recessive Centronuclear Myopathy	MYH7 SELENON	3.61e-03	15	178	2	C3645536
Disease	proprotein convertase subtilisin/kexin type 7 measurement	DSCAML1 TAGLN	4.64e-03	17	178	2	EFO_0008270
Disease	posterior cingulate cortex volume measurement	KDM4C NDST4	4.64e-03	17	178	2	EFO_0010324
Disease	Age-related macular degeneration	HMCN1 C3	5.20e-03	18	178	2	cv:C0242383
Disease	Congenital Fiber Type Disproportion	MYH7 SELENON	5.20e-03	18	178	2	C0546264
Disease	atrophic macular degeneration, age-related macular degeneration, wet macular degeneration	SYN3 CFHR5 C3	5.74e-03	60	178	3	EFO_0001365, EFO_0004683, EFO_1001492
Disease	Lewy body dementia (is_marker_for)	ANXA5 TARDBP	5.78e-03	19	178	2	DOID:12217 (is_marker_for)
Disease	cardiomyopathy (is_implicated_in)	MYH7 SRF	5.78e-03	19	178	2	DOID:0050700 (is_implicated_in)
Disease	Hereditary Non-Polyposis Colon Cancer Type 2	MSH3 PTPRJ	5.78e-03	19	178	2	C1333991
Disease	Colorectal cancer, hereditary nonpolyposis, type 1	MSH3 PTPRJ	5.78e-03	19	178	2	C2936783

Protein segments in the cluster

Peptide	Gene	Start	Entry
MSTAQSLKSVDYEVF	ACYP2	1	P14621
MAEGNTLISVDYEIF	ACYP1	1	P07311
DQVESGSYDKEVSSM	CCDC186	706	Q7Z3E2
SGMDVTIVKTDYEGQ	AGK	91	Q53H12
YINESNDKGETALMV	ANKRD34C	36	P0C6C1
MVAAAETITTDSEKY	CUL5	326	Q93034
TSKQMDLLQEFYETT	COPS2	121	P61201
EAMGIYISTLKTEFT	AHSA1	146	O95433
YEKGQLTSSMVDDVF	COG4	441	Q9H9E3
QEEGKTVMYTAVGSE	BCS1L	161	Q9Y276
IVYIEEEMKNGTFNT	ADGRV1	5226	Q8WXG9
FSEMEYITVGDKYVS	C4orf47	16	A7E2U8
EGTSEMAVTFDKVYV	C1QTNF4	41	Q9BXJ3
YIMAIEQTIKSGSDE	C3	1561	P01024
KVNSFLTMESENYEG	ABCC9	1281	O60706
MSAEYTSKVQIFEHG	ARMC3	136	Q5W041
VEKIMQSSSEVGYDA	HSPD1	491	P10809
QYTSLLGKMNSEEED	DIABLO	116	Q9NR28
DKYMTISGFQIEETI	ANXA5	211	P08758
FVGSTTREVYKELMS	CCDC87	486	Q9NVE4
KDSVNSTLYFIDGMT	BPTF	311	Q12830
EKIVEVMFETYQFSG	ACTR2	121	P61160
SVMQKYLEDRGEVTF	GRK2	41	P25098
GVSTDKASMEVRYQT	HJURP	606	Q8NCD3
DYVSQEMVFKTLGTD	KIF16B	71	Q96L93
MKGLYFQQSSTDEEI	CRYZL1	1	O95825
MKAEVNAGFTAVYES	FAM81A	321	Q8TBF8
YQTMSGVKEADFKDL	P3H1	186	Q32P28
EGSSKTLQEVLTMEY	HIBCH	316	Q6NVY1
FDVLGFTSEEKNSMY	MYH7	336	P12883
FTSEEKNSMYKLTGA	MYH7	341	P12883
METANYTKVTEFVLT	OR4M2B	1	A0A0X1KG70
YTGKTKITDDNVEMF	KBTBD3	111	Q8NAB2
DLSVFEVDGNMSKIY	KAT6B	786	Q8WYB5
TNRYSIVSSEEDGMK	KCNJ2	6	P63252
YSITEGNIGEKFSMD	FAT1	1916	Q14517
SAQYVTVSGQEFMIE	MSH3	741	P20585
YKGQSTFMEELTDTA	MSH3	946	P20585
KQAQDYGDITVAMTS	PTPRJ	1156	Q12913
STISKSDYMEIQEGV	KCNA2	451	P16389
TFSVMDVERYVGGDK	KDM7A	176	Q6ZMT4
VMASTVVKYLSQEEA	NAXE	51	Q8NCW5
MDGVAEFSEYVSETV	MAP1A	1	P78559
SEMTSTSLYQDKQEG	MAP1B	1446	P46821
MNYKDGISSETVTAL	MED13L	881	Q71F56
IKVTYMEEERNFTTE	HSPA4	101	P34932
AAMFQIKVGSESVVY	INTS11	161	Q5TA45
DSNKIESEEVYHGTM	IMPG1	326	Q17R60
GKDVTELSQYMQEST	DST	4296	Q03001
KTFTMEGERSPNEEY	KIF11	111	P52732
DESTAEITFYMKGAD	ATP9B	646	O43861
ITEMSEKYFSQESEV	KRT80	436	Q6KB66
TLKDVFGAYSMDVIT	CYP3A4	171	P08684
ETMGHRYVEVFKSNS	HNRNPH2	76	P55795
VGNKSDLVEYSSMET	RHOT1	116	Q8IXI2
METANYTKVTEFVLT	OR4M1	1	Q8NGD0
METANYTKVTEFVLT	OR4M2	1	Q8NGB6
STFSVDKMVSVLYNV	OR4Q2	261	P0C623
EKTSGMEVASYLVAQ	NLRP1	46	Q9C000
YVMEDITFNVKVASG	GAREM1	121	Q9H706
QDTFYVIELDAGMQS	KALRN	2126	O60229
ENRGYMEIEQSVKSF	KCT2	171	Q8NC54
NSTLSKSEYMVIEEG	KCNA3	521	P22001
AVTSQTFYEVMFDDG	KDM4C	901	Q9H3R0
TEYMENGSLVDFLKT	LCK	316	P06239
SYAFNMKSVVSDEGL	HSPA1L	546	P34931
SSETIKSNTGEYVIM	GABRA6	216	Q16445
AKGEVTEMFSYEESN	HM13	336	Q8TCT9
ISAVTYIISMFEDDK	ENPEP	696	Q07075
LNEDMYIQITDFGTA	PDPK2P	186	Q6A1A2
MSTTVNVDSLAEYEK	PLCG2	1	P16885
QIEYAMEAVKQGSAT	PSMA1	21	P25786
DAGFKLMVVEYAEST	POGK	201	Q9P215
GYKQEMTLIETTAEA	NDST4	36	Q9H3R1
VLYISMSDSDKVGVF	PADI2	201	Q9Y2J8
SMEQGKVSSVFYTNV	OR8B3	266	Q8NGG8
VQKMNLEVIYGDTDS	POLA1	991	P09884
SMYDDLVQVIEGASK	HMCN1	51	Q96RW7
IMGQFTDSDYSDPVK	PTPRQ	1921	Q9UMZ3
QSMFSIDKYTGEIQF	DCHS2	2081	Q6V1P9
DSMKYSIFSGNEDGV	DCHS2	2171	Q6V1P9
TFLVRDASTKMQGDY	PIK3R3	86	Q92569
LDEVQSYSGVNKMSV	ARHGAP24	271	Q8N264
ILNFLKTMDYETSES	DAAM1	161	Q9Y4D1
YLQAVEDGKSTTTME	G2E3	616	Q7L622
SQFEYNVEGVTSKEM	COL1A2	1236	P08123
ASSIVEASVEIYNKM	DNAH6	2266	Q9C0G6
YTVSLLVTEGQEKMD	IGSF22	151	Q8N9C0
ETAVSAFEIDKMYTP	FBXO9	416	Q9UK97
QYSIVEMKATGDSEV	DSCAML1	1036	Q8TD84
TTAETLDVQMKGEFY	BPI	246	P17213
FIGEFSTTFEEMQKA	CPNE7	316	Q9UBL6
TMQKEEDTSGYRAQI	DSP	1381	P15924
NIITINEFSDKSMYT	DNAH7	2111	Q8WXX0
HMADYSVFQVEISKG	DNAH7	2356	Q8WXX0
ISDMGKNVSATDIEY	HYAL4	171	Q2M3T9
TTIYEIQDKTGSMAV	PYHIN1	341	Q6K0P9
KETSTAEMEYQSGVT	CCDC183	286	Q5T5S1
IDSMTKQAIVYEGQD	EBF1	131	Q9UH73
SQVMTSDVFYELSKD	BTBD7	431	Q9P203
MTTTVNYQDGEKVAV	CFHR5	401	Q9BXR6
DGSYSMQIEDKTFQV	MCCC1	571	Q96RQ3
FGTASEDVFSYEVVM	CYBB	391	P04839
TYSMGQKVTSFDQVK	KLF18	96	A0A0U1RQI7
VKDKESGMSSLYVFN	EMC1	591	Q8N766
IDSMTKQAIVYEGQD	EBF3	131	Q9H4W6
GQIMDSETFEKSRLY	ZMPSTE24	56	O75844
MKETVDAEGRTSFYE	H6PD	241	O95479
LTKEVMSSYIQSEFA	SLC22A20P	306	A6NK97
MDTVTVFDFKTGQID	IFT140	606	Q96RY7
FIKTVGMVAGDEETY	CKMT1A	101	P12532
INLMKTSDSYGFKEE	PTPRK	876	Q15262
SMEQGKVSSVFYTNV	OR8B2	266	Q96RD0
SETEVQEKMIGQFSY	RP1	471	P56715
YTFEIEAMNGVSELS	EPHA6	411	Q9UF33
NSVKEDTAAAVMYTV	OR1P1	281	Q8NH06
FFEMVNTITEEKGRS	MAP3K5	646	Q99683
ILNKTSGQMEVYDAE	POLR1E	91	Q9GZS1
VTSYKDIESLMSEGN	KIF13B	191	Q9NQT8
ETKDGFMFLTDQSYI	MET	221	P08581
LTETSFESMIEYENK	RTN4	771	Q9NQC3
DFQDITSVVAMAKTY	SYN3	266	O14994
SVVVKYTDNIMKGFS	SLC35A1	261	P78382
FTLGQVEVSMEYDTA	SYT12	151	Q8IV01
NEGVIEFVSYSDMKR	SRSF4	141	Q08170
METNELKYSTNEGET	SORL1	556	Q92673
GETTETSDGMNFTKY	PRUNE2	1441	Q8WUY3
KEYFSTFGEVLMVQV	TARDBP	121	Q13148
VSINSQGEYEEALKM	NBR1	56	Q14596
VGKDKSAMATEYFDS	NPHP3	911	Q7Z494
EIEDAEKYSFMATVT	AHCYL1	21	O43865
YKDATTMESIVNEYA	SAMD9L	1351	Q8IVG5
IKSTETGQYLAMDTD	FGF1	71	P05230
MTVKTNETGYQEAIV	MICU2	211	Q8IYU8
MISVSSAEYGTNAKE	PRRC2C	2171	Q9Y520
YSEVQFADKMGKAST	CD84	316	Q9UIB8
EQKIYTEDMAFGAST	SECISBP2	61	Q96T21
SVEQGKMVAVFYTTV	OR5M8	266	Q8NGP6
YATNSEEVIGVMSKE	PRDM1	91	O75626
HTQMDVTDYKGETVF	PLA2G6	176	O60733
AEDYGVIKTDMFQTV	TAGLN	101	Q01995
TNEGVIEFRSYSDMK	SRSF6	146	Q13247
TEKDSYVVAFSDEMV	RO60	406	P10155
VTEGLDYGFMKEVTF	SVEP1	2901	Q4LDE5
YETEMSKTALQFRTE	SULT1B1	281	O43704
KNSFVMEYVGEIITS	SUV39H1	266	O43463
MSATGFEETDLTYQV	SRF	236	P11831
GDQDINVVSTYISKM	NT5E	521	P21589
VESAYSDIVKMISAN	PPP2R5A	116	Q15172
KFIEQSYSSVAEMRE	ATP1A4	466	Q13733
MTSEITYAEVRFKNE	CLEC4A	1	Q9UMR7
NTKEIFGVAVYTGME	ATP11B	251	Q9Y2G3
IYEDEMKQEIGSRSS	USP53	641	Q70EK8
KVLEMEASTYDGVFI	TRAF2	341	Q12933
AFVKQPSEMEDVTYS	WWC2	676	Q6AWC2
TISEFILSEDYNKMT	WDFY2	91	Q96P53
YEAEMSLQGEVNIKS	USP16	481	Q9Y5T5
YQDVMSETFKNLTSV	ZFP57	41	Q9NU63
VTAGTAEEFTYIMKR	RBP3	1146	P10745
GKTMDYAEVSNTFVR	POLR3C	136	Q9BUI4
VVAMALSGYTDEKNS	MIOS	556	Q9NXC5
SSEHKVMEVTFQGEY	NUFIP2	526	Q7Z417
MELTKLSDQTGYVEY	TTYH2	196	Q9BSA4
YKQSFKTAEIGMTEN	PLEKHG4B	1046	Q96PX9
TEEKENTFSQIYMET	RBAK	111	Q9NYW8
DVDKVYMTFVQATSS	SPATA20	146	Q8TB22
TINAGEELTFDYQMK	SUV39H2	361	Q9H5I1
SSSFMEEIQGYDVEF	TRAF6	46	Q9Y4K3
EDPSTATYMQFLKEG	SELENON	566	Q9NZV5
MSFVAYEELIKEGDT	TRMT61A	1	Q96FX7
VETMEDLVTYTKNLG	VCL	151	P18206
KVFVESSETLDYQMA	USP47	791	Q96K76
TMSQSIIDYFSGLKD	WDR72	386	Q3MJ13
SSMLGENSEFVAYVK	ZBED8	246	Q8IZ13
GFAYVEISSKEMTVT	ACP5	291	P13686
EMTVTYIEASGKSLF	ACP5	301	P13686
SFTYDETAGMLKTIN	TENM4	2031	Q6N022
MVEAEPKFSSSYEEV	SLFN12	341	Q8IYM2
DTIDDKVGAAISMTY	SRPRA	591	P08240
ESVKYTQQTMEEALG	VWA5A	341	O00534
ATDSYIEKVMISSNA	POLR3B	861	Q9NW08
TVYGDVDLSNKINEM	ROBO1	1036	Q9Y6N7
TGVTTELNDTVYMKA	ZNF518A	496	Q6AHZ1
LDVEVSASGYTKEMQ	RIOK2	296	Q9BVS4
VQKYEVSESDQMSGV	ZNF770	566	Q6IQ21
TRNSAEGTEYFKMLV	WASHC4	981	Q2M389
FGDGTQMVTEDSVVY	TMEM130	181	Q8N3G9
STQSLFEYMKGIQSD	TBCD	1001	Q9BTW9
YSQDKTGMVDFALES	SUN1	606	O94901
VMDEFGISKSTFYDI	TIGD7	31	Q6NT04
TATMKSGNSDVYENE	PC	851	P11498
MIVAVEKDSFQASGY	TGFBR3	461	Q03167
YMFNEKGTSLTPEEE	TRPC7	31	Q9HCX4
QEIQMSGSKYIFESI	MYBPC3	401	Q14896